Movatterモバイル変換

[0]ホーム
URL:

ES398372A1 - Process for the detection and determination of specific binding proteins and their corresponding bindable substances - Google Patents

Process for the detection and determination of specific binding proteins and their corresponding bindable substances

Info

Publication number
ES398372A1
ES398372A1ES398372AES398372AES398372A1ES 398372 A1ES398372 A1ES 398372A1ES 398372 AES398372 AES 398372AES 398372 AES398372 AES 398372AES 398372 A1ES398372 A1ES 398372A1
Authority
ES
Spain
Prior art keywords
specific binding
determination
detection
binding proteins
binding protein
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES398372A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NVfiledCriticalOrganon NV
Publication of ES398372A1publicationCriticalpatent/ES398372A1/en
Expiredlegal-statusCriticalCurrent

Links

Classifications

Landscapes

Abstract

The invention relates to a process for the detection and determination of a component of the reaction between a specific binding protein and the corresponding bindable substance contacting a fluid containing one of these components with a conjugate of the bindable substance with an enzyme and of antibodies against the specific binding protein which latter component is brought in an insoluble form, if necessary, in combination with the specific binding protein, and determining the activity of the liquid or solid phase of the resulting reaction mixture.
ES398372A1970-12-281971-12-27Process for the detection and determination of specific binding proteins and their corresponding bindable substancesExpiredES398372A1 (en)

Applications Claiming Priority (1)

Application NumberPriority DateFiling DateTitle
NL707018838ANL154599B (en)1970-12-281970-12-28 PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.

Publications (1)

Publication NumberPublication Date
ES398372A1true ES398372A1 (en)1975-06-16

Family

ID=19811894

Family Applications (1)

Application NumberTitlePriority DateFiling Date
ES398372AExpiredES398372A1 (en)1970-12-281971-12-27Process for the detection and determination of specific binding proteins and their corresponding bindable substances

Country Status (20)

CountryLink
US (1)US3839153A (en)
JP (3)JPS5834783B1 (en)
AT (1)AT320145B (en)
AU (1)AU467394B2 (en)
BE (1)BE777309A (en)
BR (1)BR7108553D0 (en)
CA (1)CA964560A (en)
CH (1)CH557030A (en)
DE (1)DE2164768B2 (en)
DK (1)DK150690C (en)
EG (1)EG11604A (en)
ES (1)ES398372A1 (en)
FI (1)FI54034C (en)
FR (1)FR2120835A5 (en)
GB (1)GB1348938A (en)
IL (1)IL38371A (en)
IT (1)IT965020B (en)
NL (1)NL154599B (en)
SE (1)SE398557B (en)
ZA (1)ZA718332B (en)

Families Citing this family (871)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
USRE31006E (en)*1968-09-241982-08-03Akzona IncorporatedProcess for the demonstration and determination of reaction components having specific binding affinity for each other
NL171930C (en)*1972-05-111983-06-01Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3790447A (en)*1972-07-051974-02-05Abbott LabStreptococci diagnostic method
DE2333434C3 (en)*1973-06-301978-04-06Istvan D. Dr. 5024 Pulheim Bartos Process for carrying out serological tests according to the principle of the complement fixation reaction and ready-to-use rapid test pack for this
US4239746A (en)*1973-06-301980-12-16Dezso Istvan BartosComplement fixation test employing reactants in a disposable package
US3935074A (en)*1973-12-171976-01-27Syva CompanyAntibody steric hindrance immunoassay with two antibodies
GB1508132A (en)*1974-05-201978-04-19Technicon InstrAnalysis of biological fluids
US4040907A (en)*1974-06-201977-08-09Syva CompanyIodothyronine enzyme conjugates
US4001087A (en)*1974-10-101977-01-04The United States Of AmericaAffinity labelling enzymes with esters of aromatic sulfonic acids
FR2288312A1 (en)*1974-10-141976-05-14Pasteur Institut PROGESTERONE IMMUNOENZYMATIC ASSAY PROCESS
US4002532A (en)*1974-10-211977-01-11Weltman Joel KEnzyme conjugates
SE388694B (en)*1975-01-271976-10-11Kabi Ab WAY TO PROVIDE AN ANTIGEN EXV IN SAMPLES OF BODY WHEATS, USING POROST BERAR MATERIAL BONDED OR ADSORBING ANTIBODIES
NL7501215A (en)*1975-02-011976-08-03Akzo Nv METHOD FOR DETERMINING AND DETERMINING AN ANTIGEN OR ANTIBODY.
US4629688A (en)*1975-04-281986-12-16Miles Laboratories, Inc.Homogeneous specific binding assay method
US4230797A (en)*1975-04-281980-10-28Miles Laboratories, Inc.Heterogenous specific binding assay employing a coenzyme as label
USRE32696E (en)*1975-09-041988-06-14Akzona IncorporatedEnzymatic immunological method for determination of antigens and antibodies
SE7610683L (en)*1975-09-291977-06-10Cordis Corp METHOD OF DETERMINING THE NERVARON OF AN ANTIGEN ASSOCIATE WITH HEPATITIS
US4642285A (en)*1975-09-291987-02-10Diamedix CorporationSandwich EIA for antigen
US4474878A (en)*1975-09-291984-10-02Cordis Laboratories, Inc.Sandwich EIA for antigen associated with hepatitis
JPS5272284A (en)*1975-12-121977-06-16Dainippon Pharmaceutical CoEnzymeeimmunoassay reagent
US4045384A (en)*1976-07-231977-08-30The Dow Chemical CompanyMethod for forming an amide bond between a latex and protein
GB1549069A (en)*1976-12-101979-08-01Erba FarmitaliaEnzyme linked immunoassay
US4200690A (en)*1976-12-161980-04-29Millipore CorporationImmunoassay with membrane immobilized antibody
US4407943A (en)*1976-12-161983-10-04Millipore CorporationImmobilized antibody or antigen for immunoassay
JPS5399319A (en)*1977-02-091978-08-30Hidematsu HiraiNovel qualitative and quantitative detecting method and detecting body for antgenic substance
IT1114861B (en)*1977-05-121986-01-27Sclavo Inst Sieroterapeut METHOD FOR DETERMINING THE CONTENT OF CONSTITUENTS OF BIOLOGICAL FLUIDS AND MEANS SUITABLE FOR THE PURPOSE
AU531777B2 (en)*1978-04-051983-09-08Syva Co.Label/solid conjugate immunoassay system
US4233402A (en)*1978-04-051980-11-11Syva CompanyReagents and method employing channeling
US4492751A (en)*1978-04-101985-01-08Miles Laboratories, Inc.Heterogenous specific binding assay employing an enzyme substrate as label
US4318980A (en)*1978-04-101982-03-09Miles Laboratories, Inc.Heterogenous specific binding assay employing a cycling reactant as label
FR2422956A1 (en)*1978-04-131979-11-09Pasteur Institut METHOD OF DETECTION AND CHARACTERIZATION OF A NUCLEIC ACID OR OF A SEQUENCE OF THE SAME, AND ENZYMATIC REAGENT FOR THE IMPLEMENTATION OF THIS PROCESS
US5605800A (en)*1978-04-131997-02-25Institut PasteurMethod of detecting and characterizing a nucleic acid or a sequence of the latter, and enzymatic reactant for the application of this method
JPS5510590A (en)*1978-05-041980-01-25Wellcome FoundEnzyme immunity quantity analysis
JPS5539702A (en)*1978-08-301980-03-19Takeda Chem Ind LtdMethod of measuring enzyme immunity of pancreas glucagon
FR2440555A1 (en)*1978-10-311980-05-30Maes Roland IMPROVEMENTS IN METHODS OF DETERMINING SUBSTANCES SHOWING SPECIFIC BINDING AFFINITIES BETWEEN THEM, BY TESTS INVOLVING A SOLID PHASE
US4260678A (en)*1979-02-231981-04-07Corning Glass WorksDetermining creatine kinase isoenzmes via immobilized antibody-isoenzyme complexes
JPS55152459A (en)*1979-05-181980-11-27Yamasa Shoyu Co LtdMethod and reagent for measuring quantity of cyclic nucleotide
US4289748A (en)*1979-05-311981-09-15United States Of AmericaUltrasensitive enzymatic radioimmunoassay method
DE2930706A1 (en)*1979-07-281981-02-05Medac Klinische Spezialpraep METHOD FOR DETECTING POTENTIAL-SPECIFIC ANTIBODY
US4299916A (en)*1979-12-261981-11-10Syva CompanyPreferential signal production on a surface in immunoassays
US4394391A (en)*1980-02-191983-07-19Thorell Jan IvanRadioimmunoassay reagents
US4322495A (en)*1980-03-111982-03-30Minnesota Mining And Manufacturing Co.Immunoassay
EP0040728A1 (en)*1980-05-191981-12-02Pharmacia Diagnostics AbAn improvement in and relating to assaying methods involving biospecific affinity reactions
SE8003732L (en)*1980-05-191981-11-20Pharmacia Diagnostics Ab SET FOR DETERMINATION METHODS INVOLVING BIOSPECIFIC AFFINITY REACTIONS
JPS5714748A (en)*1980-07-011982-01-26Dainippon Pharmaceut Co LtdKit for quantitative determination of valproic acid and its method for quantitative determination
US4323647A (en)*1980-10-151982-04-06University Of MiamiSteric hindrance enzyme immunoassay
DE3048884A1 (en)*1980-12-231982-07-15Boehringer Mannheim Gmbh, 6800 Mannheim METHOD FOR ENZYME IMMUNE DETERMINATION IN HETEROGENEOUS PHASE
ES8307897A1 (en)*1981-04-131983-08-01Hoechst Co AmericanSingle incubation immunochemical assay for creatin phosphokinase MB.
US4604365A (en)*1981-06-021986-08-05Electro-Nucleonics, Inc.Immunoprecipitation assay
DE3265823D1 (en)*1981-06-021985-10-03Electro NucleonicsImmunoprecipitation assay
US4506009A (en)*1982-03-301985-03-19University Of CaliforniaHeterogeneous immunoassay method
US4535057A (en)*1982-07-261985-08-13Amf IncorporatedImmunoassay employing monoclonal herpes simplex antibody and biotin-avidin detection system
US4515890A (en)*1982-11-081985-05-07Abbott LaboratoriesImmunoassay of terminal deoxynucleotidyl transferase
US4650751A (en)*1983-04-291987-03-17Technicon Instruments CorporationProtected binding assay avoiding non-specific protein interference
US4778752A (en)*1983-10-111988-10-18Scripps Clinic And Research FoundationReceptors specific for hapten-modified self proteins
AU593795B2 (en)*1985-03-181990-02-22Royal Free Hospital School Of MedicineImprovements relating to the detection of cytomegalovirus and antibodies
JPS62148857A (en)*1985-12-241987-07-02Toyo Soda Mfg Co Ltd Method for manufacturing immunoassay materials
EP0247730A3 (en)*1986-04-281989-04-12Antibody Technology LimitedAntibodies, their preparation and use and products containing them
DE3636724A1 (en)*1986-10-291988-06-23Joern Dr Med KekowEnzyme immunoassay (ELISA) for determining insulin in an microtitre plate system
US6528292B1 (en)*1987-05-292003-03-04Aventis Pharmaceuticals Holdings Inc.Derivatized polystyrene and other polymer supports for spectroscopic studies
US5256372A (en)*1987-11-061993-10-26Idexx CorporationDipstick test device including a removable filter assembly
US5137804A (en)*1988-05-101992-08-11E. I. Du Pont De Nemours And CompanyAssay device and immunoassay
US5374524A (en)*1988-05-101994-12-20E. I. Du Pont De Nemours And CompanySolution sandwich hybridization, capture and detection of amplified nucleic acids
US5614504A (en)*1990-08-011997-03-25The University Of South FloridaMethod of making inosine monophosphate derivatives and immunopotentiating uses thereof
DE69230000T2 (en)*1991-07-192000-05-11Cytimmune Sciences, Inc. METHOD AND TEST SET FOR MEASURING ENDOGENIC CYTOKINS
US5965379A (en)*1991-07-191999-10-12Cytimmune Sciences Inc.Method for measuring endogenous cytokines
US5464749A (en)1991-07-221995-11-07Bayer CorporationImmunoassay of free substances in biological fluids
US5874423A (en)*1992-09-101999-02-23Yissum Research Development Co. Of The Hebrew University Of JerusalemDigitalis-like compounds
US5637467A (en)*1992-10-131997-06-10Behringwerke AgHeterogeneous assay using a pendulous drop
WO1995034640A1 (en)*1994-06-131995-12-21Henry Ford Health SystemA novel neuronal-neonatal gene: neuronatin
US6531277B2 (en)1994-10-252003-03-11The Curators Of The University Of MissouriEndometriosis-specific secretory protein
US5843673A (en)*1994-10-251998-12-01Curators Of The University Of MissouriMethod of screening for endometriosis
US20030152909A1 (en)*1994-11-162003-08-14Mitrani Eduardo N.In vitro micro-organs, and uses related thereto
US5607565A (en)*1995-03-271997-03-04Coulter CorporationApparatus for measuring analytes in a fluid sample
US5777093A (en)*1995-05-161998-07-07Ramot-University Authority For Applied Research & Industrial Development Ltd.cDNAs associated with ataxia-telangiectasia
US5728807A (en)*1995-05-161998-03-17Ramot-University Authority For Applied Research And Industrial Development, Ltd.Mutated proteins associated with ataxia-telangiectasia
US5858661A (en)*1995-05-161999-01-12Ramot-University Authority For Applied Research And Industrial DevelopmentAtaxia-telangiectasia gene and its genomic organization
US6096508A (en)*1995-08-162000-08-01Kirkegaard & Perry Laboratoies, Inc.Method of reducing background in biotin-based assays
US5840322A (en)*1996-12-191998-11-24Ramot-University Authority For Applied Research & Industrial Devel. Ltd.Anti-oral-microbial adhesion fraction derived from vaccinium
ATE293633T1 (en)1997-08-212005-05-15Quark Biotech Inc HYPOXIA-REGULATED GENES
US7973156B2 (en)1997-08-212011-07-05Quark Pharmaceuticals Inc.Hypoxia-regulated genes
US6284496B1 (en)1997-10-032001-09-04University Of South FloridaDNA vector for determining the presence of out-of-reading-frame mutations
AU748467B2 (en)1997-10-172002-06-06University Of South FloridaMethod to diagnose and monitor cellular immune deficiencies
US7687057B2 (en)1998-01-092010-03-30Yissum Research Development Company Of The Hebrew University Of JerusalemIn vitro micro-organs, and uses related thereto
US20080206206A1 (en)1998-05-072008-08-28University Of South FloridaBone marrow-derived neuronal cells
US6344443B1 (en)1998-07-082002-02-05University Of South FloridaPeptide antagonists of tumor necrosis factor alpha
AU4994899A (en)1998-07-132000-02-01University Of South FloridaModulation of the phospholipase a2 pathway as a therapeutic
US6187563B1 (en)1998-08-072001-02-13Yale UniversityβIV-spectrin-polypeptides and nucleic acids encoding same
BR9914465A (en)1998-09-292001-10-09Gamida Cell Ltd Methods to control the proliferation and differentiation of stem cells and progenitor cells and a pharmaceutical composition to induce differentiation in a cell population
AU759719B2 (en)1999-02-042003-04-17Pluristem Ltd.Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells
US6440682B1 (en)*1999-05-282002-08-27Detroit R&D Inc.Detection of hypertension using immunoreactive metabolic products
US6787318B1 (en)*1999-06-012004-09-07Roskamp Research Institute, LlcAssay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
US7534605B2 (en)1999-06-082009-05-19Yissum Research Development Company Of The Hebrew University Of JerusalemCD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases
WO2001000859A1 (en)*1999-06-252001-01-04Yissum Research Development Company Of The Hebrew University Of JerusalemMethod of inducing angiogenesis by micro-organs
US6875582B1 (en)1999-08-192005-04-05Omniscience Pharmaceuticals, Inc.Methods and targets of antibiotic resistance
US7811981B2 (en)1999-08-302010-10-12Yissum Research Development Company Of The Hebrew University Of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US7101839B1 (en)1999-08-302006-09-05Yissum Research Development Company Of The Hebrew University Of JerusalemMethods of and compositions for inhibiting the proliferation of mammalian cells
US6998232B1 (en)1999-09-272006-02-14Quark Biotech, Inc.Methods of diagnosing bladder cancer
HK1048139B (en)*1999-11-192006-12-29Yissum Research Development Company Of The Hebrew University Of JerusalemAspegillus niger beta-glucosidase gene, protein and uses thereof
US6544506B2 (en)2000-01-052003-04-08Yeda Research & Development Co. Ltd.Veto cells effective in preventing graft rejection and devoid of graft versus host potential
EP1252292A4 (en)*2000-01-242004-11-17Univ RamotPlants tolerant of environmental stress conditions, methods of generating same and novel polynucleotide sequence utilized thereby
US20040191260A1 (en)*2003-03-262004-09-30Technion Research & Development Foundation Ltd.Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof
ATE472601T1 (en)2000-03-272010-07-15Technion Res And Dev Of Founda CLASS I SINGLE-CHAIN MAIN HISTOCOMPATIBILITY COMPLEXES (MHC-I), CODING CONSTRUCTS AND METHODS OF THEIR GENERATION
IL135884A (en)*2000-04-302005-08-31Yissum Res Dev CoMethod for measuring non-transferrin bound iron
HUP0300810A2 (en)2000-07-202003-08-28M.G.V.S. Ltd.Artifical vascular grafts, and methods of producing and using same
US20040037828A1 (en)2002-07-092004-02-26Bar-Ilan UniversityMethods and pharmaceutical compositions for healing wounds
DK1315519T3 (en)2000-08-082011-04-11Technion Res & Dev Foundation Pharmaceutical compositions and methods that can be used to treat cancer or liver fibrosis
US20030114410A1 (en)*2000-08-082003-06-19Technion Research And Development Foundation Ltd.Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
EP1683874A3 (en)2000-08-292006-10-11YEDA RESEARCH AND DEVELOPMENT Co. LTD.Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
US7632522B2 (en)*2000-09-282009-12-15Nanocyte Inc.Use of stinging cells/capsules for the delivery of active agents to keratinous substances
US20070281037A9 (en)*2000-09-282007-12-06Nanocyte Inc.Sterile preparations and compositions including stinging capsules and methods of producing and using same
WO2002026191A2 (en)*2000-09-282002-04-04Nanocyte Inc.Methods, compositions and devices utilizing stinging cells/capsules for delivering a therapeutic or a cosmetic agent into a tissue
ES2338529T3 (en)2000-11-172010-05-10Vascular Biogenics Ltd. PROMETERS THAT EXHIBIT SPECIFICITY FOR ENDOTELIAL CELLS AND METHODS FOR USE.
US8071740B2 (en)2000-11-172011-12-06Vascular Biogenics Ltd.Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
AU2002218461B2 (en)2000-11-242006-09-07Vascular Biogenics LtdMethods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
WO2002044736A2 (en)2000-11-302002-06-06Molecular Skincare LimitedDiagnosis and treatment of epidermal or skin diseases
EP1337152A4 (en)*2000-11-302004-08-11Yeda Res & Dev METHOD FOR USING BREEDED NON-GVHD INDUCING T-LYMPHOCYTES FOR TREATING DISEASES
AU2002236608A1 (en)*2000-12-142002-06-24Nyxis Neurotherapies, Inc.High throughput assay to detect inhibitors of the map kinase pathway
US7087395B1 (en)2001-01-162006-08-08Quest Diagnostics Investments IncorporatedVitamin D assay
US20040078842A1 (en)*2001-01-172004-04-22Aviah ZilbersteinChitinases, derived from carnivorous plants polynucleotide sequences encoding thereof, and methods of isolating and using same
CA2475021A1 (en)*2001-01-312002-08-08Dror MevorachInduction of tolerance by apoptotic and/or necrotic cells
US20050202098A1 (en)*2001-01-312005-09-15TolarenDisease therapy using dying or dead cells
US20030003454A1 (en)2001-03-232003-01-02Yeda Research And Development Co. Ltd. At The Weizmann Institute Of ScienceMethods and kits for determining a risk to develop cancer, for evaluating an effectiveness and dosage of cancer therapy and for correlating between an activity of a DNA repair enzyme and a cancer
US6770622B2 (en)2001-06-082004-08-03Gary A. JarvisN-terminally truncated galectin-3 for use in treating cancer
US20050022269A1 (en)*2001-07-192005-01-27Joseph HirschbergPolypeptides having carotenoids isomerase catalytic activity, nucleic acids encoding same and uses thereof
US7442781B2 (en)2001-08-162008-10-28Urifer Ltd.Diagnosis, prevention and treatment of cancer
US7138144B2 (en)*2001-09-072006-11-21Nadir AskenasyMethod of inducing immune tolerance via blood/lymph flow-restricted bone marrow transplantation
US20040136972A1 (en)2001-09-072004-07-15Yeda Research And Development Co. Ltd.Methods of treating disease by transplantation of developing allogeneic or xenogeneic organs or tissues
DE60237777D1 (en)2001-10-192010-11-04Vascular Biogenics Ltd EFFECTS AND METHODS FOR THE TARGETED DOWN ALLGATION OF ANGIOGENESIS AND CANCER THERAPY
AUPR842501A0 (en)*2001-10-232001-11-15Epipop Pty LtdA method for identification and development of therapeutic agents
US8178128B2 (en)*2001-12-052012-05-15Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Nanoparticles containing polymeric nucleic acid homologs
US20050085432A1 (en)*2001-12-262005-04-21Aviva LapidotMethods of using conjugates of saccharides and acetamidino or guanidino compounds for treating bacterial infections
IL152904A0 (en)*2002-01-242003-06-24Gamida Cell LtdUtilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
EP1465982A4 (en)2002-01-252006-06-07Gamida Cell LtdMethods of expanding stem and progenitor cells and expanded cell populations obtained thereby
US7781396B2 (en)*2002-01-312010-08-24Tel Aviv University Future Technology Development L.P.Peptides directed for diagnosis and treatment of amyloid-associated disease
US20040052928A1 (en)*2002-09-062004-03-18Ehud GazitPeptides and methods using same for diagnosing and treating amyloid-associated diseases
US6992176B2 (en)*2002-02-132006-01-31Technion Research & Development Foundation Ltd.Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease
CA2476625A1 (en)*2002-02-202003-08-28Dyax Corp.Mhc-peptide complex binding ligands
WO2003078567A2 (en)*2002-03-182003-09-25Gamida-Cell Ltd.Methods of inducing differentiation in ex vivo expanded stem cells
WO2003079967A2 (en)*2002-03-262003-10-02Nanocyte Inc.Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue
US20040121442A1 (en)*2002-05-052004-06-24Ilan ChetFungal chitinase, polynucleotide sequences encoding same, promoters of same, and uses thereof
AU2003242967A1 (en)*2002-07-122004-02-02Yissum Research Development Company Of The Hebrew University Of JerusalemMethod and device for inducing biological processes by micro-organs
CA2494348C (en)2002-08-012014-04-08Yeda Research And Development Co. Ltd.Method and composition for protecting neuronal tissue from damage induced by elevated glutamate levels
US7267981B2 (en)2002-10-072007-09-11Technion Research & Development Foundation Ltd.Human foreskin fibroblasts for culturing ES cells
US20040146949A1 (en)*2002-10-252004-07-29Jun TanMethods and compounds for disruption of CD40R/CD40L signaling in the treatment of alzheimer's disease
CA2504512A1 (en)2002-10-302004-05-13Yissum Research Development Company Of The Hebrew University Of JerusalemMolecules and methods using same for measuring non-transferrin bound iron
US20050054097A1 (en)*2002-11-172005-03-10Tony PeledEX-VIVO expansion of hematopoietic system cell populations in mononuclear cell cultures
WO2004050826A2 (en)*2002-11-292004-06-17Technion Research & Development Foundation Ltd.Method of dynamically culturing embryonic stem cells
US7491699B2 (en)*2002-12-092009-02-17Ramot At Tel Aviv University Ltd.Peptide nanostructures and methods of generating and using the same
WO2004052275A2 (en)2002-12-122004-06-24R.B.T. (Rakuto Bio Technologies) Ltd.Methods of producing lignin peroxidase and its use in skin and hair lightening
PT1572984E (en)2002-12-162016-06-03Technion Res & Dev FoundationFeeder-free, xeno-free culture system for human embryonic stem cells
CA2512499A1 (en)2003-01-022004-07-22Rappaport Family Institute For Research In The Medical SciencesMethods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
EP2058275A1 (en)2003-01-072009-05-13Ramot at Tel-Aviv University Ltd.Peptide nanostructures encapsulating a foreign material and method of manufacturing same
EP1599598A4 (en)2003-03-042007-08-08Yeda Res & DevPon polypeptides, polynucleotides encoding same and compositions and methods utilizing same
AU2004217699B2 (en)*2003-03-072008-07-03Gamida-Cell Ltd.Expansion of renewable stem cell populations using modulators of PI 3-kinase
US8017113B2 (en)2003-03-122011-09-13Rappaport Family Institute For Research In The Medical SciencesCompositions and methods for diagnosing and treating an inflammation
US7294701B2 (en)*2003-04-022007-11-13Technion Research & Development Foundation Ltd.Antibody fragment capable of modulating multidrug resistance and compositions and kits and methods using same
EP2330132B1 (en)2003-04-042013-08-14Yeda Research and Development Co. Ltd.Antibodies against MMP2 or MMP9 and pharmaceutical compositions containing same useful for inhibiting activity of said metalloproteins
CA2520023C (en)2003-04-082013-02-05Yeda Research And Development Co. LtdStem cells having increased sensitivity to sdf-1 and methods of generating and using same
FR2853551B1 (en)2003-04-092006-08-04Lab Francais Du Fractionnement STABILIZING FORMULATION FOR IMMUNOGLOBULIN G COMPOSITIONS IN LIQUID FORM AND LYOPHILIZED FORM
US7321065B2 (en)*2003-04-182008-01-22The Regents Of The University Of CaliforniaThyronamine derivatives and analogs and methods of use thereof
CN101942449B (en)2003-05-222014-07-02伊沃基因有限公司Methods of increasing abiotic stress tolerance and/or biomass in plants and plants generated thereby
US7554007B2 (en)2003-05-222009-06-30Evogene Ltd.Methods of increasing abiotic stress tolerance and/or biomass in plants
AU2005234725B2 (en)2003-05-222012-02-23Evogene Ltd.Methods of Increasing Abiotic Stress Tolerance and/or Biomass in Plants and Plants Generated Thereby
US20050020499A1 (en)*2003-05-272005-01-27Bar Ilan UniversityMethods of attenuating cocaine seeking behavior employing glial cell-derived neurotrophic factor (GDNF) and pharmaceutical compositions and articles of manufacture suited for use in practice of the method
US8129514B2 (en)*2003-06-192012-03-06Evogene Ltd.Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
WO2004111183A2 (en)*2003-06-192004-12-23Evogene Ltd.Plant trichome-specific promoter and leucoplast signal sequence
CN101415724B (en)*2003-06-302015-12-02特拉维夫大学未来科技开发有限公司Peptide, anti-peptide antibody and carry out the method for Diagnosis and Treat diseases associated with amyloid protein with them
EP1654348A4 (en)*2003-08-142008-02-13Bio Balance CorpBacterial strains, compositions including same and probiotic use thereof
WO2005031362A2 (en)2003-10-022005-04-07Ramot At Tel Aviv University Ltd.Novel antibacterial agents and methods of identifying and utilizing same
IL158287A0 (en)2003-10-072004-05-12Yeda Res & DevAntibodies to nik, their preparation and use
PT1678209E (en)2003-10-072011-06-30Yeda Res & DevAntibodies to nik, their preparation and use
MXPA06004537A (en)*2003-10-232006-06-23Pfizer Prod IncVaccine for periodontal disease.
WO2005051423A2 (en)2003-11-302005-06-09Yeda Research And Development Co. LtdMethods and agents for immune modulation and methods for identifying immune modulators
WO2005059100A2 (en)*2003-12-122005-06-30New York UniversityMethods and compositions relating to cystatin c
US20100221233A1 (en)*2003-12-152010-09-02University Of South FloridaCompositions and methods for enhancing neuroprotection via administration of stem cells and blood brain barrier permeabilizers
DK1722834T3 (en)2003-12-222012-10-22Regentis Biomaterials Ltd Matrix, which includes naturally occurring cross-linked protein skeleton
US8007847B2 (en)2004-01-132011-08-30Eytan BidermanFeeding formula appliance
US7423139B2 (en)*2004-01-202008-09-09Insight Biopharmaceuticals Ltd.High level expression of recombinant human erythropoietin having a modified 5′-UTR
WO2005071058A2 (en)*2004-01-272005-08-04Compugen Ltd.Methods and systems for annotating biomolecular sequences
EP3006039B1 (en)2004-03-022021-01-06Acceleron Pharma Inc.Alk7 polypeptides for use in promoting fat loss
US8352031B2 (en)2004-03-102013-01-08Impulse Dynamics NvProtein activity modification
EP1766058A4 (en)2004-06-142008-05-21Evogene LtdPolynucleotides and polypeptides involved in plant fiber development and methods of using same
US8680062B2 (en)*2004-07-062014-03-25Deliversir Ltd.System for delivering therapeutic agents into living cells and cells nuclei
US20090156471A1 (en)*2004-07-152009-06-18Ramot At Tel Aviv University Ltd.Use of anti-amyloid agents for treating and typing pathogen infections
EP1799812A4 (en)2004-09-162009-09-09Gamida Cell LtdMethods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
US8000900B2 (en)2004-09-212011-08-16Microsoft CorporationAssociation-based predictions of pathogen characteristics
US20060095241A1 (en)*2004-10-292006-05-04Microsoft CorporationSystems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
ES2524601T3 (en)*2004-09-292014-12-10Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Recombinant human T2 RNase and uses thereof
CA2582051C (en)2004-09-292015-08-11Collplant Ltd.Collagen producing plants and methods of generating and using same
EP1809374A4 (en)*2004-10-122008-09-10Closed Loop Therapies LtdMethods and implantable devices for treating supraventricular arrhythmias
US8478535B2 (en)2004-10-292013-07-02Microsoft CorporationSystems and methods that utilize machine learning algorithms to facilitate assembly of aids vaccine cocktails
US20060134680A1 (en)*2004-12-222006-06-22Alexander KotlyarHomogeneous populations of nucleic acids, methods of synthesyzing same and uses thereof
WO2006075334A2 (en)2005-01-162006-07-20Zlango Ltd.Iconic communication
WO2006075335A2 (en)*2005-01-162006-07-20Zlango Ltd.Communications network system and methods for using same
US8019818B2 (en)*2005-01-182011-09-13Zlango Ltd.Communications network system and methods for using same
DK1843850T3 (en)2005-01-312015-12-07Realbio Technologies Ltd LATERAL FLOW STEERING CAPILLAR DEVICE
EP2316441A1 (en)2005-02-172011-05-04Hadasit Medical Research Services And DevelopmentBisphosphonates for treating endometriosis
US8216801B2 (en)2005-02-252012-07-10The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization, (A.R.O.), The Volcani CenterMethods for treating inflammatory disorders
US7695927B2 (en)*2005-03-182010-04-13Detroit R & DDetection of hypertension using glucuronidated metabolic products
WO2006109312A2 (en)*2005-04-152006-10-19Vascular Biogenics Ltd.Compositions containing beta 2-glycoprotein i-derived peptides for the prevention and/or treatment of vascular disease
US8834862B2 (en)*2005-04-192014-09-16Nanocyte Inc.Methods, compositions and devices utilizing stinging cells/capsules for conditioning a tissue prior to delivery of an active agent
CA2606018A1 (en)*2005-04-282006-11-02Ventana Medical Systems, Inc.Nanoparticle conjugates
EP1877101B1 (en)2005-04-282016-11-16Ventana Medical Systems, Inc.Enzymes conjugated to antibodies via a peg heterobifuctional linker
EP1888034A2 (en)2005-05-262008-02-20Yissum Research Development Company, of The Hebrew University of JerusalemCompositions and methods using same for delivering agents into a target organ protected by a blood barrier
WO2006134602A2 (en)2005-06-162006-12-21Ramot At Tel Aviv University Ltd.Isolated cells and populations comprising same for the treatment of cns diseases
US20070225242A1 (en)*2005-06-212007-09-27The Board Of Trustees Of The Leland Stanford Junior UniversityMethod and composition for treating and preventing tumor metastasis in vivo
EP1904526A4 (en)2005-07-072009-10-28Fulcrum Sp LtdSp1 polypeptides, modified sp1 polypeptides and uses thereof
EP1915448B1 (en)*2005-07-072013-09-04Yissum Research Development Company, of The Hebrew University of JerusalemNucleic acid agents for downregulating h19, and methods of using same
EP2484768A3 (en)2005-07-182012-11-21Protalix Ltd.Mucosal or enteral administration of biologically active macromolecules
WO2007014304A2 (en)2005-07-262007-02-01University Of Medicine And Dentistry Of New JerseyAntibody profiles characteristic of tuberculosis state
EP1945257A4 (en)*2005-08-082009-05-06Onconon LlcAntibody compositions, methods for treating neoplastic disease and methods for regulating fertility
EP1928479B1 (en)2005-08-242016-06-08Yeda Research And Development Co., Ltd.Universal donor-derived tolerogenic cells for inducing non-syngeneic transplantation tolerance
WO2007026353A2 (en)2005-08-292007-03-08Technion Research & Development Foundation Ltd.Media for culturing stem cells
DE602006014009D1 (en)2005-09-222010-06-10Yissum Res Dev Co NUCLEIC ACID CONSTRUCTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT OF CANCER
US20070087437A1 (en)*2005-10-142007-04-19Jifan HuMethods for rejuvenating cells in vitro and in vivo
BRPI0618965B1 (en)2005-10-242021-01-12Evogene Ltd method to increase a plant's tolerance to an abiotic stress condition, method to increase a plant's biomass, vigor and / or yield, method to increase the efficiency of fertilizer use and / or absorption of a plant
EP1950166B1 (en)*2005-11-182014-05-07Mitsubishi Denki Kabushiki KaishaDevice for lighting elevator car
CN101535244B (en)*2005-11-232014-07-23文塔納医疗系统公司 molecular conjugate
EP1974012B1 (en)2005-11-292013-02-27Gamida Cell Ltd.Methods of improving stem cell homing and engraftment
US8846393B2 (en)2005-11-292014-09-30Gamida-Cell Ltd.Methods of improving stem cell homing and engraftment
EP2237037A1 (en)2005-12-122010-10-06Gyros Patent AbMicrofluidic device and use thereof
US20070134739A1 (en)*2005-12-122007-06-14Gyros Patent AbMicrofluidic assays and microfluidic devices
US8775526B2 (en)2006-01-162014-07-08Zlango Ltd.Iconic communication
US8476234B2 (en)2006-02-032013-07-02Prolor Biotech Inc.Long-acting coagulation factors and methods of producing same
US8759292B2 (en)2006-02-032014-06-24Prolor Biotech, LlcLong-acting coagulation factors and methods of producing same
US9458444B2 (en)2006-02-032016-10-04Opko Biologics Ltd.Long-acting coagulation factors and methods of producing same
US7553940B2 (en)2006-02-032009-06-30Modigene IncLong-acting EPO polypeptides and derivatives thereof and methods thereof
US10221228B2 (en)2006-02-032019-03-05Opko Biologics Ltd.Long-acting polypeptides and methods of producing and administering same
US10351615B2 (en)2006-02-032019-07-16Opko Biologics Ltd.Methods of treatment with long-acting growth hormone
US20140113860A1 (en)2006-02-032014-04-24Prolor Biotech Ltd.Long-acting polypeptides and methods of producing and administering same
US8946155B2 (en)2006-02-032015-02-03Opko Biologics Ltd.Long-acting polypeptides and methods of producing and administering same
US9249407B2 (en)2006-02-032016-02-02Opko Biologics Ltd.Long-acting coagulation factors and methods of producing same
US8450269B2 (en)2006-02-032013-05-28Prolor Biotech Ltd.Long-acting growth hormone and methods of producing same
US8048849B2 (en)2006-02-032011-11-01Modigene, Inc.Long-acting polypeptides and methods of producing same
US8048848B2 (en)2006-02-032011-11-01Prolor Biotech Ltd.Long-acting interferons and derivatives thereof and methods thereof
US20150038413A1 (en)2006-02-032015-02-05Opko Biologics Ltd.Long-acting polypeptides and methods of producing and administering same
CN101416063A (en)2006-02-062009-04-22拉帕波特家族医学科学研究所Methods and kit for diagnosing T1DM
ES2553637T3 (en)2006-03-062015-12-10Zetiq Technologies Ltd. Methods to identify a cellular phenotype
WO2007108003A2 (en)2006-03-232007-09-27Pluristem Ltd.Methods for cell expansion and uses of cells and conditioned media produced thereby for therapy
EP2004858A4 (en)2006-03-282009-12-09Tel Hashomer Medical Res Infrastructure & Services Ltd METHODS AND KITS FOR DETERMINING PREDISPOSITION TO WARFARIN RESISTANCE
AU2007234733A1 (en)*2006-04-072007-10-18The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human ServicesAntibody compositions and methods for treatment of neoplastic disease
WO2007136778A2 (en)*2006-05-192007-11-29Teva Pharmaceutical Industries, Ltd.Fusion proteins, uses thereof and processes for producing same
US20070281883A1 (en)*2006-06-052007-12-06Hanna RosenfeldDevelopment of follicle stimulating hormone agonists and antagonists in fish
EP2046109A4 (en)2006-07-202010-01-06Yeda Res & DevPhotosyntheticorganisms and compositions and methods of generating same
US8809052B2 (en)2006-08-282014-08-19Yeda Research And Development Co. Ltd.Methods of generating mature oligodendrocytes
US7888059B2 (en)*2006-10-052011-02-15Yeda Research And Development Co. Ltd.Highly purified and stabilized Na,K-ATPase isoforms and methods of producing same
ES2426754T3 (en)2006-10-052013-10-25Technion Research & Development Foundation Ltd. Microtubes and methods to produce them
AU2007335706B2 (en)*2006-12-202013-03-28Evogene Ltd.Polynucleotides and polypeptides involved in plant fiber development and methods of using same
CA2675964C (en)*2007-01-162015-12-22Yissum Research Development Company Of The Hebrew University Of JerusalemH19 silencing nucleic acid agents for treating rheumatoid arthritis
US20100196403A1 (en)*2007-01-292010-08-05Jacob HochmanAntibody conjugates for circumventing multi-drug resistance
WO2008093341A2 (en)2007-01-312008-08-07Technion Research & Development Foundation Ltd.Electrospun scaffolds and methods of generating and using same
EP2125050B1 (en)2007-02-012014-07-30Technion Research & Development Foundation Ltd.Albumin fibers and fabrics and methods of generating and using same
EP2839839B1 (en)2007-02-282018-01-17Yeda Research And Development Company LimitedNuclear targeting sequences
WO2008120202A2 (en)2007-03-292008-10-09Technion Research & Development Foundation Ltd.Antibodies, methods and kits for diagnosing and treating melanoma
EP2142661B1 (en)2007-04-022012-08-29Ramot at Tel-Aviv University Ltd.Methods of detecting cancer cells and use of same for diagnosing and monitoring treatment of the disease
WO2008122980A2 (en)2007-04-092008-10-16Evogene Ltd.Polynucleotides, polypeptides and methods for increasing oil content, growth rate and biomass of plants
US9556210B2 (en)2007-04-232017-01-31Sabag-Rfa Ltd.System for delivering therapeutic agents into living cells and cells nuclei
EP2144633B1 (en)*2007-04-232014-07-16Deliversir LtdA system for delivering therapeutic agents into living cells and cells nuclei
US9156865B2 (en)2007-04-232015-10-13Deliversir LtdSystem for delivering therapeutic agents into living cells and cells nuclei
ES2564312T3 (en)2007-05-012016-03-21Tel Hashomer Medical Research Infrastructure And Services Ltd. Methods and kits to detect fetal cells in maternal blood
GB2462048B (en)2007-05-032012-03-21Agency Science Tech & ResAntibodies binding to an intracellular prl-1 or prl-3 polypeptide
WO2008135991A2 (en)2007-05-072008-11-13Protalix Ltd.Large scale disposable bioreactor
ATE540115T1 (en)2007-07-112012-01-15Yeda Res & Dev NUCLEIC ACID CONSTRUCT SYSTEMS WITH CAPABILITY TO DIAGNOSE OR TREAT A CELL CONDITION
IL184627A0 (en)2007-07-152008-12-29Technion Res & Dev FoundationAgents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
CA2696833A1 (en)2007-07-152009-01-22Yitzchak HillmanDisease treatment via antimicrobial peptides or their inhibitors
EP2910638B1 (en)2007-07-242018-05-30Evogene Ltd.Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance and/or biomass and/or yield in plants expressing same
ES2534490T3 (en)2007-08-022015-04-23Gilead Biologics, Inc. LOX and LOXL2 inhibitors and uses thereof
KR20100071972A (en)2007-08-152010-06-29예다 리서치 앤드 디벨럽먼트 캄파니 리미티드Regulators of mmp-9 and uses therof
EP2195650B1 (en)2007-09-122016-07-06Yeda Research And Development Company Ltd.Methods of treating tumors in immune-privileged sites
EP3103463B1 (en)2007-09-192020-01-01Pluristem Ltd.Adherent cells from adipose or placenta tissues and use thereof in therapy
WO2009050691A2 (en)2007-10-192009-04-23Rappaport Family Institute For Research In The Medical SciencesCompositions comprising semaphorins for the treatment of angiogenesis related diseases and methods of selection thereof
JP2011504374A (en)2007-11-262011-02-10イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム リミテッド Composition comprising fibrous polypeptide and polysaccharide
BRPI0819476A2 (en)2007-12-272015-07-14Evogene Ltd Method of improving a plant's abiotic stress tolerance, method of improving water use efficiency, fertilizer use efficiency, biomass, vigor and / or yield of a plant, isolated polynucleotide, nucleic acid construct, isolated polypeptide, plant cell "
WO2009095925A2 (en)*2008-01-312009-08-06Compugen Ltd.Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
EP2250302B1 (en)2008-02-212014-05-21Technion Research and Development Foundation, Ltd.Use of electrospun microtubes for drug delivery
US8747855B2 (en)*2008-04-092014-06-10Technion Research & Development Foundation LimitedAnti human immunodeficiency antibodies and uses thereof
EP2297200A1 (en)*2008-04-092011-03-23Technion Research & Development Foundation Ltd.Anti influenza antibodies and uses thereof
EP2274153B1 (en)*2008-04-102012-07-04Objet Ltd.System and method for three dimensional model printing
CN102056619A (en)2008-04-182011-05-11科尔普兰特有限公司 Methods of Producing and Using Procollagen
DK2268129T3 (en)2008-04-212015-09-28Danziger Innovations LtdPLANTEVIRUSEKSPRESSIONSVEKTORER AND USE THEREOF FOR GENERATING GENOTYPEVARIATIONER into plant genomes
JP2010043063A (en)2008-05-092010-02-25Agency For Science Technology & ResearchDiagnosis and treatment of kawasaki disease
CA3148194A1 (en)2008-05-222009-11-26Evogene Ltd.Isolated polynucleotides and peptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
RU2515156C2 (en)2008-05-272014-05-10Плуристем Лтд.Methods of treating inflammatory diseases of colon
WO2009144718A1 (en)2008-05-282009-12-03Ramot At Tel Aviv University Ltd.Mesenchymal stem cells for the treatment of cns diseases
CN102076415B (en)2008-06-292015-06-24瑞尔比奥技术有限公司Liquid-transfer device particularly useful as a capturing device in a biological assay process
US20120122800A1 (en)2008-08-082012-05-17Genisphere, LLC Hatfield, PennsylvaniaLong-Acting DNA Dendrimers and Methods Thereof
CN102176914B (en)2008-08-082014-12-17新加坡科技研究局VHZ for diagnosis and treatment of cancers
US9018445B2 (en)2008-08-182015-04-28Evogene Ltd.Use of CAD genes to increase nitrogen use efficiency and low nitrogen tolerance to a plant
US8524496B2 (en)2008-09-022013-09-03Pluristem Ltd.Adherent cells from placenta tissue and use thereof in therapy
US8367392B2 (en)*2008-09-052013-02-05Transalgae Ltd.Genetic transformation of algal and cyanobacteria cells by microporation
US20110305682A1 (en)2008-09-112011-12-15Ben Gurion University Of The Negev Research And Development AuthorityCompositions and Methods for Treating S. Pneumonia Infection
BRPI0919020A2 (en)2008-09-122017-08-22Univ South Florida USE OF ENRICHED MONOCYTE LINE CELLS TO TREAT ISCHEMIA AND TO TREAT ANGINA PECTORIS
EP2789626B1 (en)2008-09-242018-07-18Tel HaShomer Medical Research Infrastructure and Services Ltd.Peptides and compositions for prevention of cell adhesion and methods of using same
US20110178024A1 (en)2008-09-292011-07-21Ben Gurion University Of The Negev Research And Development AuthorityAmyloid beta-peptides and methods of use thereof
BRPI0914522B1 (en)2008-10-302019-04-02Evogene Ltd METHOD FOR INCREASING YIELD, BIOMASS, GROWTH RATE, STRENGTH, OIL OTEOR, AND / OR EFFICIENCY OF NITROGEN USE OF A PLANT
US20110229892A1 (en)2008-11-172011-09-22Yehuda G AssarafMethod for predicting a patient's responsiveness to anti-folate therapy
WO2010058396A1 (en)2008-11-192010-05-27Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.A cd44vra antibody and diagnostic and therapeutic methods using same
WO2010061383A1 (en)2008-11-262010-06-03Biodalia Microbiological Technologies Ltd.A method of in-situ enrichment of foods with fructan
WO2010064231A1 (en)2008-12-022010-06-10Tel Hashomer Medical Research Infrastructure And Services Ltd.Methods of analyzing a-i rna editing and nucleic acid constructs capable of same
US20120014927A1 (en)2008-12-032012-01-19Tel Hashomer Medical Research Infrastructure And Services Ltd.Methods and kits for determining predisposition to cancer
EP2633854B1 (en)2008-12-052015-09-16Yeda Research And Development Co. Ltd.miRNA-9 or miRNA-9* for use in treating ALS
WO2010071610A1 (en)2008-12-192010-06-24Agency For Science, Technology And Research (A*Star)Severe chikungunya biomarkers
EP2376653A2 (en)2008-12-292011-10-19Yissum Research Development Company of The Hebrew University of JerusalemMethods of predicting responsiveness to interferon treatment and treating hepatitis c infection
WO2010076756A2 (en)2008-12-292010-07-08Evogene Ltd.Polynucleotides, polypeptides encoded thereby, and methods of using same for increasing abiotic stress tolerance, biomass and/or yield in plants expressing same
SG10201401054YA (en)2008-12-292014-07-30Tel Hashomer Medical Res Infrastructure & Services LtdPeptides and compositions for prevention of cell adhesion and methods of using same
WO2010076794A1 (en)2008-12-312010-07-08Technion Research & Development Foundation Ltd.Method of denitrifying brine and systems capable of same
WO2010080769A2 (en)2009-01-062010-07-15Arresto Biosciences, Inc.Chemotherapeutic methods and compositions
IL196820A0 (en)2009-02-012009-11-18Yissum Res Dev CoDevitalized, acellular scaffold matrices derived from micro-organs seeded with various cells
WO2010086867A2 (en)2009-02-022010-08-05Ramot At Tel Aviv University Ltd.Peptides, pharmaceutical compositions comprising same and uses thereof
WO2010089707A1 (en)2009-02-042010-08-12Yeda Research And Development Co. Ltd.Methods and kits for determining sensitivity or resistance of prostate cancer to radiation therapy
WO2010097794A1 (en)2009-02-262010-09-02Tel Hashomer Medical Research Infrastructure And Services Ltd.Methods of reprogramming renal cells
MX351466B (en)2009-03-022017-10-16Evogene LtdIsolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics.
HRP20160385T1 (en)2009-03-092016-05-06Ramot At Tel-Aviv University Ltd.Compositions and methods for prevention and treatment of neurodegenerative diseases
WO2010103517A1 (en)2009-03-122010-09-16Rappaport Family Institute For Research In The Medical SciencesSoluble compositions for the treatment of cxcr3-ligand associated diseases
EP2414542B1 (en)2009-03-302017-08-30Tel HaShomer Medical Research Infrastructure and Services Ltd.Methods of predicting clinical course and treating multiple sclerosis
CA2759201A1 (en)2009-04-012010-10-07The Medical Research, Infrastructure, And Health Services Fund Of The Te L Aviv Medical CenterA method of regulating proliferation and differentiation of keratinocyes
WO2010116375A1 (en)2009-04-082010-10-14Yeda Research And Development Co. Ltd.Isolated peptides for regulating apoptosis
PL2424896T3 (en)2009-04-302016-03-31Tel Hashomer Medical Res Infrastructure & Services LtdAnti ceacam1 antibodies and methods of using same
WO2010134073A1 (en)2009-05-192010-11-25Zetiq Technologies Ltd.Kits for and methods of differential staining of cervical cancer cells and/or tissues
US20120078163A1 (en)2009-05-272012-03-29Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method of generating connective tissue
WO2010137013A1 (en)2009-05-272010-12-02Ramot At Tel Aviv University Ltd.Crystallized photosystem i units from the pea plant and their use in solid state devices
US20120083477A1 (en)2009-05-272012-04-05Yeda Research And Development Co. Ltd.Proteasome inhibitors and uses thereof
EP2435078A1 (en)2009-05-282012-04-04Yeda Research and Development Co. Ltd.Methods of treating inflammation
ES2773985T3 (en)2009-06-102020-07-16Evogene Ltd Isolated polynucleotides and polypeptides, and methods of using them to increase nitrogen use efficiency, yield, growth rate, vigor, biomass, oil content, and / or tolerance to abiotic stress
EP2446267A1 (en)2009-06-242012-05-02Health Corporation - RambamMethods and kits for isolating placental derived microparticles and use of same for diagnosis of fetal disorders
US12203113B2 (en)2009-07-092025-01-21Opko Biologics Ltd.Long-acting coagulation factors and methods of producing same
US9663778B2 (en)2009-07-092017-05-30OPKO Biologies Ltd.Long-acting coagulation factors and methods of producing same
WO2011004379A1 (en)2009-07-102011-01-13Tel Hashomer Medical Research Infrastructure And Services Ltd.Compositions and methods for treating cancer
EP2457089B1 (en)2009-07-212019-08-07Tel HaShomer Medical Research Infrastructure and Services Ltd.A method of diagnosing cancer
GB0913442D0 (en)2009-07-312009-09-16Univ RamotCell-targeting nanoparticles comprising polynucleotide agents and uses thereof
US20120148546A1 (en)2009-08-172012-06-14Technion Research & Development Foundation Ltd.Pericyte progenitor cells and methods of generating and using same
EP2467146A1 (en)2009-08-212012-06-27Beeologics Inc.Preventing and curing beneficial insect diseases via plant transcribed molecules
AU2010284036B2 (en)2009-08-212014-12-18Gilead Biologics, Inc.Catalytic domains from lysyl oxidase and LOXL2
CA2771774A1 (en)*2009-08-212011-02-24Gilead Biologics, Inc.In vitro screening assays
WO2011024172A2 (en)2009-08-272011-03-03Technion Research & Development Foundation Ltd.Liposomal compositions and uses of same
WO2011030336A1 (en)2009-09-082011-03-17Ramot At Tel-Aviv University Ltd.Methods of diagnosing amyotrophic lateral sclerosis (als)
EP2475381A2 (en)2009-09-082012-07-18Yeda Research and Development Co. Ltd.Methods for hematopoietic precursor mobilization
WO2011030329A1 (en)2009-09-102011-03-17Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method of treating tumors
US8735124B2 (en)2009-09-172014-05-27Yeda Research And Development Co. Ltd.Isolated PON1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
EP2478093A2 (en)2009-09-172012-07-25Yeda Research and Development Co. Ltd.Isolated pon1 polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
EP2478009B1 (en)2009-09-172016-06-01Ramot at Tel-Aviv University Ltd.Peptides for the treatment of oxidative stress related disorders
US20110081706A1 (en)*2009-10-022011-04-07TransAlgae LtdMethod and system for efficient harvesting of microalgae and cyanobacteria
CN102906263B (en)2009-10-142017-05-31耶路撒冷希伯来大学伊森姆研究发展公司 Compositions for controlling Varroa mites in bees
US8962584B2 (en)2009-10-142015-02-24Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd.Compositions for controlling Varroa mites in bees
JP2013508013A (en)2009-10-162013-03-07ザ ユニバーシティ オブ メディスン アンド デンティストリー オブ ニュー ジャージー Method of treating chronic neural tissue injury using cell therapy strategy
WO2011048600A1 (en)2009-10-212011-04-28Danziger Innovations Ltd.Generating genotypic variations in plant genomes by gamete infection
IL201999A (en)2009-11-082017-10-31Medical Res & Development Fund For Health Services Bnai Zion Medical Center The State Of IsraelKnock-out mouse of the mo-1 gene, a gene associated with morbid obesity
WO2011058555A1 (en)2009-11-122011-05-19Yeda Research And Development Co. Ltd.A method of editing dna in a cell and constructs capable of same
EP3633025B1 (en)2009-11-122022-09-14Technion Research & Development Foundation Ltd.Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
WO2011058557A1 (en)2009-11-122011-05-19Ramot At Tel-Aviv University Ltd.Compositions comprising pedf and uses of same in the treatment and prevention of ovary-related syndromes
WO2011061736A1 (en)2009-11-172011-05-26Protalix Ltd.Alkaline alpha galactosidase for the treatment of fabry disease
US20120273993A1 (en)2009-11-242012-11-01Collplant Ltd.Method of generating collagen fibers
EP2977445B1 (en)2009-11-302018-07-25Pluristem Ltd.Adherent cells from placenta and use of same in disease treatment
US9562235B2 (en)2009-12-062017-02-07A.B. Seeds Ltd.MicroRNA compositions and methods for enhancing plant resistance to abiotic stress
WO2011072091A1 (en)2009-12-092011-06-16Quark Pharmaceuticals, Inc.Methods and compositions for treating diseases, disorders or injury of the cns
CA3172119A1 (en)2009-12-282011-07-07Evogene Ltd.Isolated polynucleotides and polypeptides and methods of using same for increasing plant yield, biomass, growth rate, vigor, oil content, abiotic stress tolerance of plants and nitrogen use efficiency
WO2011080740A1 (en)2009-12-292011-07-07Gamida-Cell Ltd.Methods for enhancing natural killer cell proliferation and activity
SG10201500013SA (en)2010-01-052015-03-30Vascular Biogenics LtdMethods for use of a specific anti-angiogenic adenoviral agent
US20130052165A1 (en)2010-01-122013-02-28Livnat BangioMethods of Producing Adenovirus Vectors and Viral Preparations Generated Thereby
US8697078B2 (en)2010-01-272014-04-15Yeda Research And Development Co. Ltd.Antibodies that inhibit metalloproteins
KR20130008021A (en)2010-02-042013-01-21길리아드 바이오로직스, 인크.Antibodies that bind to lysyl oxidase-like 2 (loxl2) and methods of use therefor
WO2011099006A2 (en)2010-02-112011-08-18Yeda Research And Development Co. Ltd.Enzymatic systems for carbon fixation and methods of generating same
AU2011219426A1 (en)2010-02-242012-10-04Ben Gurion University Of The Negev Research And Development AuthorityMethods for inhibiting necrosis
WO2011107939A1 (en)2010-03-012011-09-09Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
WO2011107994A1 (en)2010-03-042011-09-09Yeda Research And Development Co. Ltd.Methods of measuring protein stability
NZ627060A (en)2010-03-082016-01-29Monsanto Technology LlcPolynucleotide molecules for gene regulation in plants
EP2545176B1 (en)2010-03-082016-05-11Yeda Research and Development Co. Ltd.Recombinant protein production in heterologous systems
CN102918159A (en)2010-03-112013-02-06雅各布·埃德尔 method of producing hydrogen
US9073990B2 (en)2010-04-052015-07-07Bar-Llan UniversityProtease-activatable pore-forming polypeptides
US8927274B2 (en)2010-04-122015-01-06Technion Research & Development Foundation LimitedPopulations of pancreatic progenitor cells and methods of isolating and using same
EP2557913B1 (en)2010-04-122016-08-03Ben Gurion University Of The Negev Research And Development AuthoritySulfotransferase of a red microalga and uses thereof
IN2012MN02247A (en)2010-04-182015-06-12Yeda Res & Dev
EP2563112A4 (en)2010-04-282014-03-05Evogene LtdIsolated polynucleotides and polypeptides, and methods of using same for increasing plant yield and/or agricultural characteristics
WO2011138778A2 (en)2010-05-042011-11-10Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods of identifying inhibitors of polypeptides-of-interest
EP2566500B1 (en)2010-05-052017-04-12Rappaport Family Institute for Research in the Medical SciencesCcl1 for use in therapy
IL208820A0 (en)2010-10-192011-01-31Rachel TeitelbaumBiologic female contraceptives
US20130059325A1 (en)2010-05-132013-03-07Tel HaShomer Medical Research Infratructure and Services Ltd.Isolated populations of adult renal cells and methods of isolating and using same
EP2390664B1 (en)2010-05-252013-04-17Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Method for electrochemical detection of binding reactions
CA2800257C (en)2010-05-262019-03-05The Board Of Trustees Of The University Of IllinoisPersonal glucose meters for detection and quantification of a broad range of analytes
US9624285B2 (en)2010-06-032017-04-18Ramot a Tel-Aviv University Ltd.Methods of treating diabetes and compositions capable of same
BR112012031045A2 (en)2010-06-072017-06-20Ashur Fabian Osnat methods for detecting a condition, for determining the efficacy of a therapeutic treatment of a condition, and for selecting a subject suffering from a condition, and, kit.
US20130097731A1 (en)2010-06-162013-04-18Futuragene Israel Ltd.Pest-resistant plants containing a combination of a spider toxin and a chitinase
US9187787B2 (en)2010-06-162015-11-17Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method of diagnosing and treating cancer
US9512188B2 (en)2010-07-122016-12-06The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)Isolated polynucleotides and methods and plants using same for regulating plant acidity
JP2013538555A (en)2010-07-152013-10-17テクニオン リサーチ アンド ディベロップメント ファウンデーション リミテッド An isolated high affinity entity with T cell receptor-like specificity for a natural complex of MHC class II and glutamate decarboxylase (GAD) autoantigenic peptide
WO2012007919A2 (en)2010-07-152012-01-19Technion Research & Development Foundation Ltd.Nucleic acid construct for increasing abiotic stress tolerance in plants
WO2012007950A2 (en)2010-07-152012-01-19Technion Research & Development Foundation Ltd.Isolated high affinity entities with t-cell receptor like specificity towards native complexes of mhc class ii and diabetes-associated autoantigenic peptides
US9624469B2 (en)2010-07-222017-04-18Cellect Biotherapeutics Ltd.Regulatory immune cells with enhanced targeted cell death effect
US20130130387A1 (en)2010-07-272013-05-23Technion Research & Development Foundation LimitedMethod for generating induced pluripotent stem cells from keratinocytes derived from plucked hair follicles
US20130130311A1 (en)2010-07-272013-05-23Yeda Research And Development Co., Ltd.Methods and systems for assessing clonality of cell cultures
WO2012014205A1 (en)2010-07-272012-02-02Technion Research & Development Foundation Ltd.Isolated mesenchymal progenitor cells and extracellular matrix produced thereby
WO2012017439A2 (en)2010-08-042012-02-09Ramot At Tel-Aviv University Ltd.Methods of treating autoimmune diseases of the central nervous system (cns) and neurodegenerative diseases
SG187830A1 (en)2010-08-222013-03-28Univ RamotInduced pluripotent stem cells derived from human pancreatic beta cells
WO2012025925A1 (en)2010-08-242012-03-01Rappaport Family Institute For Research In The Medical SciencesMethods of improving transplantation using sdf-1alpha
AR082530A1 (en)2010-08-302012-12-12Evogene Ltd POLINUCLEOTIDES AND ISOLATED POLYPEPTIDES, AND METHODS TO USE THEM TO INCREASE EFFECTIVENESS IN THE USE OF NITROGEN, PERFORMANCE, GROWTH RATE, VIGOR, BIOMASS, OIL CONTENT AND / OR TOLERANCE TO STRESS ABIOTI
EP3572501B1 (en)2010-09-072025-07-16Technion Research & Development Foundation LimitedNovel methods and culture media for culturing pluripotent stem cells
WO2012032510A1 (en)2010-09-072012-03-15Yeda Research And Development Co. Ltd.Primers for amplifying dna and methods of selecting same
WO2012032519A2 (en)2010-09-072012-03-15Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods of diagnosing parkinson's disease
WO2012032520A1 (en)2010-09-072012-03-15Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Readthrough acetylcholinesterase (ache-r) for treating or preventing parkinson's disease
WO2012032525A2 (en)2010-09-082012-03-15Yeda Research And Development Co. Ltd.An immunosuppressive drug combination for a stable and long term engraftment
SG188473A1 (en)2010-09-082013-05-31Yeda Res & DevUse of anti third party central memory t cells for anti-leukemia/lymphoma treatment
EP2616539A1 (en)2010-09-152013-07-24Ramot at Tel-Aviv University Ltd.Methods of expanding and redifferentiating islet beta cells
WO2012038956A1 (en)2010-09-202012-03-29Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method of treating neurodegenerative diseases
EP3075396A1 (en)2010-10-172016-10-05Yeda Research and Development Co. Ltd.Methods and compositions for the treatment of insulin-associated medical conditions
WO2012052878A1 (en)2010-10-192012-04-26Vascular Biogenics Ltd.Isolated polynucleotides and nucleic acid constructs for directing expression of a gene-of-interest in cells
US20130216603A1 (en)2010-10-272013-08-22Nanocyte (Israel) Ltd.Pharmaceutical compositions and delivery devices comprising stinging cells or capsules
US10066024B2 (en)2010-10-282018-09-04Yeda Research And Development Co. Ltd.Methods of generating antibodies to metalloenzymes
US20130227724A1 (en)2010-11-032013-08-29Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Transgenic plants with improved saccharification yields and methods of generating same
EP2635105B1 (en)2010-11-042017-12-20Ben-Gurion University of The Negev Research and Development AuthorityAcyl-coa: diacylglycerol acyltransferase 1-like gene (ptdgat1) and uses thereof
AR083885A1 (en)2010-11-152013-03-27Univ Ramot ANALOGS OF DIPEPTIDES FOR THE TREATMENT OF AFFECTIONS ASSOCIATED WITH THE FORMATION OF AMILOID FIBRILLES
WO2012066495A2 (en)2010-11-172012-05-24Ben Gurion University Of The Negev Research And Development AuthorityT-cell therapy to neurodegenerative diseases
WO2012073238A1 (en)2010-12-022012-06-07Technion Research & Development Foundation Ltd.Methods of generating corneal cells and cell populations comprising same
US20120183960A1 (en)2010-12-072012-07-19Enterologics, Inc.Method for identifying e. coli m-17
JP5922147B2 (en)2010-12-152016-05-24カディマステム リミテッド Insulin-producing cells derived from pluripotent stem cells
BR122021002248B1 (en)2010-12-222022-02-15Evogene Ltd METHOD TO INCREASE TOLERANCE TO ABIOTIC STRESS, PRODUCTION, BIOMASS, AND/OR GROWTH RATE OF A PLANT
CN103533947A (en)2010-12-282014-01-22卡梅迪斯有限公司Plant extracts for the treatment and prevention of infections
EP2665814B1 (en)2011-01-202017-05-17Protalix Ltd.Nucleic acid construct for expression of alpha-galactosidase in plants and plant cells
WO2012104851A1 (en)2011-01-312012-08-09Yeda Research And Development Co. Ltd.Methods of diagnosing disease using overlap extension pcr
US20130330349A1 (en)2011-02-232013-12-12Rappaport Family Institute For Research In The Medical SciencesHigh affinity molecules capable of binding a type a plexin receptor and uses of same
CN103597078B (en)2011-03-022016-12-14富途锐基尼以色列有限公司 Antibacterial transgenic plants with a dysfunctional T3SS protein
WO2012117373A1 (en)2011-03-032012-09-07Ramot At Tel-Aviv University Ltd.Genetically modified muscle cells which express neurotrophic factors
MX346663B (en)2011-03-062017-03-27Merck Serono SaLow fucose cell lines and uses thereof.
WO2012120518A1 (en)2011-03-082012-09-13Ramot At Tel-Aviv University Ltd.Compositions and methods for diagnosing and treating phenylketonuria (pku)
KR20140019385A (en)2011-03-172014-02-14라모트 앳 텔-아비브 유니버시티 리미티드Bi- and monospecific, asymmetric antibodies and methods of generating the same
US20140086839A1 (en)2011-03-172014-03-27Tel Hashomer Medical Research Infrastructure And Services Ltd.Quinolone analogs for treating autoimmune diseases
KR101835917B1 (en)2011-03-222018-03-07플루리스템 리미티드Methods for treating radiation or chemical injury
EA201391387A1 (en)2011-03-242014-01-30Неурим Фармасьютикалс (1991) Лтд. NEUROPROTECTIVE PEPTIDES
WO2012131680A2 (en)2011-03-282012-10-04Yeda Research And Development Co. Ltd.Compositions and methods for treating inflammation
WO2012137202A1 (en)2011-04-052012-10-11Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Composition comprising an iron indicator attached to a microparticle and uses of same for quantifying non-transferrin bound iron (ntbi) and cellular labile iron (lci)
CN103518133B (en)2011-04-062016-08-17雷蒙特亚特特拉维夫大学有限公司 Method for monitoring and analyzing metabolic activity profile and its diagnostic and therapeutic use
US9150644B2 (en)2011-04-122015-10-06The United States Of America, As Represented By The Secretary, Department Of Health And Human ServicesHuman monoclonal antibodies that bind insulin-like growth factor (IGF) I and II
IL254464B2 (en)2011-04-152023-12-01Pluri Biotech Ltd Methods and systems for harvesting cells
AR086243A1 (en)2011-05-032013-11-27Evogene Ltd POLYPEPTIDES AND POLINUCLEOTIDES ISOLATED AND METHODS FOR USE, TO INCREASE PERFORMANCE, BIOMASS, GROWTH INDEX, VIGOR, OIL CONTENT, TOLERANCE TO THE ABIOTIC STRESS OF PLANTS AND EFFICIENCY IN THE USE OF THE NITER
US9192670B2 (en)2011-05-042015-11-24Ramot At Tel-Aviv University Ltd.Regulation of amyloid beta molecular composition for the treatment of alzheimer's disease
WO2012153333A1 (en)2011-05-092012-11-15Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Regeneration and repair of mesenchymal tissue using amelogenin
WO2012153336A2 (en)2011-05-122012-11-15Rakuto Bio Technologies Ltd.Methods and device for lightening skin complexion
WO2012156976A1 (en)2011-05-162012-11-22Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods of producing artemisinin in non-host plants and vectors for use in same
EP3263127B1 (en)2011-05-232019-08-21Yeda Research and Development Co. LtdUse of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
WO2012160526A2 (en)2011-05-232012-11-29Ofir MenasheFormulations of microorganism comprising particles and uses of same
JP6169567B2 (en)2011-05-312017-07-26ハチソン バイオフィルム メディカル ソリューションズ リミテッド Dispersion and detachment of cell clumps
US20140113376A1 (en)2011-06-012014-04-24Rotem SorekCompositions and methods for downregulating prokaryotic genes
US10166295B2 (en)2011-06-022019-01-01Opko Biologics Ltd.Pegylated OXM variants
WO2012172555A1 (en)2011-06-142012-12-20Yeda Research And Development Co. Ltd.Combination therapy to prevent dcis formation and progression to breast cancer
CA2838773A1 (en)2011-06-232012-12-27Kaiima Bio Agritech Ltd.Common wheat, plants or parts thereof having partially or fully multiplied genome, hybrids and products thereof and methods of generating and using same
PH12014500175A1 (en)2011-07-202014-03-03Kaiima Bio Agritech LtdMaize plants having a partially or fully multiplied genome and uses thereof
US20130030452A1 (en)2011-07-272013-01-31Health Corporation - RambamDevices for surgical applications
EP2739736B1 (en)2011-08-042017-04-19Yeda Research and Development Co. Ltd.Mir-135 and compositions comprising same for the treatment of serotonin associated medical conditions
WO2013021389A2 (en)2011-08-092013-02-14Yeda Research And Development Co.Ltd.Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
MX2014001777A (en)2011-08-142014-08-21Kaiima Bio Agritech LtdDurum wheat plants having a partially or fully multiplied genome and uses thereof.
WO2013035070A1 (en)2011-09-072013-03-14Yeda Research And Development Co. Ltd.Olfactory signature and odorant mixture having the same
EP2753351B1 (en)2011-09-082017-06-21Yeda Research and Development Co. Ltd.Anti third party central memory t cells, methods of producing same and use of same in transplantation and disease treatment
ES2657552T3 (en)2011-09-082018-03-05Yeda Research And Development Co. Ltd. New risk biomarkers for lung cancer
US10760086B2 (en)2011-09-132020-09-01Monsanto Technology LlcMethods and compositions for weed control
CN107739737A (en)2011-09-132018-02-27孟山都技术公司Method and composition for Weeds distribution
US10829828B2 (en)2011-09-132020-11-10Monsanto Technology LlcMethods and compositions for weed control
BR112014005958A2 (en)2011-09-132020-10-13Monsanto Technology Llc agricultural chemical methods and compositions for plant control, method of reducing expression of an accase gene in a plant, microbial expression cassette, method for making a polynucleotide, method of identifying polynucleotides useful in modulating expression of the accase gene and herbicidal composition
US10806146B2 (en)2011-09-132020-10-20Monsanto Technology LlcMethods and compositions for weed control
CN109997852A (en)2011-09-132019-07-12孟山都技术公司Method and composition for Weeds distribution
AU2012308694B2 (en)2011-09-132018-06-14Monsanto Technology LlcMethods and compositions for weed control
WO2013054320A1 (en)2011-10-112013-04-18Tel Hashomer Medical Research Infrastructure And Services Ltd.Antibodies to carcinoembryonic antigen-related cell adhesion molecule (ceacam)
PT2768851T (en)2011-10-212017-09-08Augurex Life Sciences CorpAntigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
EP2771464B1 (en)2011-10-272018-03-21Yeda Research and Development Co. Ltd.Methods of treating cancer
AU2012332517B9 (en)2011-11-032017-08-10Quark Pharmaceuticals, Inc.Methods and compositions for neuroprotection
WO2013070821A1 (en)2011-11-082013-05-16Quark Pharmaceuticals, Inc.Methods and compositions for treating diseases, disorders or injury of the nervous system
WO2013076729A1 (en)2011-11-232013-05-30Danziger Dan Flower FarmOtomeria plants
WO2013076730A1 (en)2011-11-272013-05-30Yeda Research And Development Co. Ltd.Methods of regulating angiogenesis and compositions capable of same
EP3034087B1 (en)2011-12-082018-03-14Yeda Research and Development Co. Ltd.Mammalian fetal pulmonary cells and therapeutic use of same
WO2013093921A1 (en)2011-12-202013-06-27Collplant Ltd.Collagen coated synthetic polymer fibers
CN105833925B (en)2011-12-222018-11-13瑞尔比奥技术有限公司sequential lateral flow capillary device for analyte determination
EP2797421B1 (en)2011-12-222020-05-20Yeda Research And Development Co. Ltd.A combination therapy for a stable and long term engraftment using specific protocols for t/b cell depletion
EP2797405A1 (en)2011-12-282014-11-05Kaiima Bio Agritech Ltd.Cultivated sorghum plant having a partially or fully multiplied genome and uses of same
EP2797632A1 (en)2012-01-012014-11-05QBI Enterprises Ltd.Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
WO2013114363A2 (en)2012-01-302013-08-08Yeda Research And Development Co.Ltd.Antimicrobial agents
US20150010527A1 (en)2012-02-012015-01-08Protalix Ltd.Dnase i polypeptides, polynucleotides encoding same, methods of producing dnase i and uses thereof in therapy
WO2013118120A2 (en)2012-02-062013-08-15Rosetta Green Ltd.Isolated polynucleotides expressing or modulating micrornas or targets of same, transgenic plants comprising same and uses thereof in improving nitrogen use efficiency, abiotic stress tolerance, biomass, vigor or yield of a plant
IN2014MN01680A (en)2012-02-132015-07-03Gamida Cell Ltd
MX362446B (en)2012-02-142019-01-18Opko Biologics LtdLong-acting coagulation factors and methods of producing same.
RU2014137404A (en)2012-02-192016-04-10Проталикс Лтд. ORAL, UNIFIED MEDICINAL FORMS AND THEIR APPLICATION FOR TREATMENT OF GACHET DISEASE
US9803175B2 (en)2012-02-222017-10-31Exostem Biotec Ltd.Generation of neural stem cells and motor neurons
EP2844744A2 (en)2012-02-222015-03-11Brainstem Biotec Ltd.MicroRNAS FOR THE GENERATION OF ASTROCYTES
EP2833714A1 (en)2012-03-012015-02-11The State of Israel - Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Volcani Center)Male sterile garlic plants, hybrid offspring of same and methods of generating and using same
CA2865486C (en)2012-03-072021-03-30Yeda Research And Development Co. Ltd.Compositions for inhibition of quiescin sulfhydryl oxidase (qsox1) and uses of same
WO2013140389A1 (en)2012-03-222013-09-26Ramot At Tel-Aviv University Ltd.Plif multimeric peptides and uses thereof
CN104271749A (en)2012-04-182015-01-07雷蒙特亚特特拉维夫大学有限公司Lipidated glycosaminoglycan particles for the delivery of nucleic acids
BR112014025951A2 (en)2012-04-192017-07-11Opko Biologics Ltd long-acting oxyntomodulin variants and production methods
US9439942B2 (en)2012-04-242016-09-13Biokine Therapeutics Ltd.Peptides and use thereof in the treatment of large cell lung cancer
ES2627816T3 (en)2012-05-092017-07-31Yeda Research And Development Co. Ltd. Variants of the pro-domain of tace as a TNF-a inhibitor and its medical use
US8865158B2 (en)2012-05-222014-10-21Ramot At Tel-Aviv University Ltd.Bacteriophages for reducing toxicity of bacteria
US9290564B2 (en)2012-05-242016-03-22Mountgate Group LimitedCompositions and methods related to the prevention and treatment of rabies infection
CN104619843B (en)2012-05-242020-03-06A.B.种子有限公司Compositions and methods for silencing gene expression
US9731048B2 (en)2012-06-032017-08-15Ben-Gurion University Of The Negev Research And Development AuthorityFunctionalized titanium binding peptides and implants coated with same
AU2013273135B2 (en)2012-06-042017-12-07Opko Biologics Ltd.Pegylated OXM variants
EP2870110A1 (en)2012-07-032015-05-13Nanospun Technologies Ltd.Methods and devices for adsorption and biodegradation of petroleum
US9175266B2 (en)2012-07-232015-11-03Gamida Cell Ltd.Enhancement of natural killer (NK) cell proliferation and activity
US9567569B2 (en)2012-07-232017-02-14Gamida Cell Ltd.Methods of culturing and expanding mesenchymal stem cells
DK2880155T3 (en)2012-07-292019-07-15Yeda Res & Dev USE OF THE REDUCING GLYCINE ROAD FOR GENERATING FORMATOTROPHIC AND AUTOTROPHIC MICRO-ORGANISMS
CN104684558A (en)2012-07-312015-06-03耶达研究及发展有限公司Methods of diagnosing and treating motor neuron diseases
CA2877223C (en)2012-08-062019-08-27Brainstorm Cell Therapeutics Ltd.Methods of generating mesenchymal stem cells which secrete neurotrophic factors
AR092868A1 (en)2012-09-032015-05-06A B Seeds Ltd METHOD FOR IMPROVING TOLERANCE TO THE ABIOTIC STRESS OF PLANTS AND PLANTS GENERATED THROUGH SUCH METHOD
EP2895197B1 (en)2012-09-122020-02-26Ramot at Tel-Aviv University Ltd.Immunoparticles and methods of generating and using same
EP2906954B1 (en)2012-10-092018-04-11Ramot at Tel-Aviv University Ltd.Methods and kits for predicting prognosis of cancer using soluble mortalin in blood
AU2013336237A1 (en)2012-10-222015-06-11Sabag-Rfa LtdA system for delivering therapeutic agents into living cells and cells nuclei
EP2912062A1 (en)2012-10-242015-09-02Yeda Research and Development Co. Ltd.Combinations of epidermal growth factor receptor targeting antibodies for treating cancer
EP2912181B1 (en)2012-10-292017-11-29Yeda Research and Development Co., Ltd.Aptamers, multimeric aptamers and uses thereof
KR102202255B1 (en)2012-11-202021-01-13옵코 바이오로직스 리미티드Method of increasing the hydrodynamic volume of polypeptides by attaching to gonadotrophin carboxy terminal peptides
CN104822390A (en)2012-11-292015-08-05耶达研究及发展有限公司Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
US10683505B2 (en)2013-01-012020-06-16Monsanto Technology LlcMethods of introducing dsRNA to plant seeds for modulating gene expression
WO2014106837A2 (en)2013-01-012014-07-10A. B. Seeds Ltd.ISOLATED dsRNA MOLECULES AND METHODS OF USING SAME FOR SILENCING TARGET MOLECULES OF INTEREST
WO2014108850A2 (en)2013-01-092014-07-17Yeda Research And Development Co. Ltd.High throughput transcriptome analysis
WO2014108854A1 (en)2013-01-092014-07-17Fusimab Ltd.Monospecific anti-hgf and anti-ang2 antibodies and bispecific anti-hgf/anti-ang2 antibodies
CA2894472C (en)2013-01-172021-08-17Novellusdx Ltd.Methods and systems for identifying patient specific driver mutations
EP2950808B1 (en)2013-02-042019-08-21Ramot at Tel-Aviv University Ltd.Generation of cytotoxic tumor specific cell lines and uses thereof
WO2014136117A1 (en)2013-03-062014-09-12Protalix Ltd.USE OF PLANT CELLS EXPRESSING A TNFalpha POLYPEPTIDE INHIBITOR IN THERAPY
AU2014224171B2 (en)2013-03-062018-02-01Protalix Ltd.Tnf alpha inhibitor polypeptides, polynucleotides encoding same, cells expressing same and methods of producing same
WO2014164761A1 (en)2013-03-132014-10-09Monsanto Technology LlcMethods and compositions for weed control
CN105263329B (en)2013-03-132020-09-18孟山都技术公司Methods and compositions for weed control
US10568328B2 (en)2013-03-152020-02-25Monsanto Technology LlcMethods and compositions for weed control
CA2907680A1 (en)2013-03-212014-09-25Collplant Ltd.Compositions comprising collagen and prp for tissue regeneration
US20160051693A1 (en)2013-03-212016-02-25Genisphere, LlcCellular Delivery of DNA Intercalating Agents
AU2014240733B2 (en)2013-03-242018-11-22Biolinerx Ltd.Methods of treating myeloid leukemia
CN105377289A (en)2013-04-212016-03-02耶达研究及发展有限公司Agents for downregulation of the activity and/or amount of bcl-xL and/or Bcl-w
JP2016521971A (en)2013-04-232016-07-28イェダ リサーチ アンド ディベロップメント カンパニー リミテッド US Patent Provisional Application No. 61/932, filed Jan. 29, 2014, based on US Patent Act 119, paragraph (e). No. 935, US Provisional Application No. 61 / 878,769, filed September 17, 2013, and US Provisional Application No. 61 / 814,920, filed April 23, 2013. In addition, this application is a U.S. patent application filed simultaneously with the same applicant's co-pending applications YacubHANNA, NoaNOVERSHTERN, and YoachRAIS (name of invention "isolated naive pluripotent stem cells and methods for generating them" It also relates to ISOLATEDNAIVEPLURIPOTENSTEMCELLSANDMETHODSOFGENERATINGSAME))) (agent case record book No. 58870). The contents of the above application are incorporated herein by reference in their entirety.
WO2014174520A1 (en)2013-04-252014-10-30Yeda Research And Development Co. Ltd.Use of inhibitory peptides for the treatment of inflammatory diseases
EP2999717B1 (en)2013-05-212018-08-08Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.Treatment of mast cell related pathologies
RU2015151047A (en)2013-05-272017-06-29Ракуто Био Текнолоджис Лтд. COSMETIC COMPOSITIONS CONTAINING AN ENZYME SYSTEM
ES2938044T3 (en)2013-06-242023-04-04Univ Ramot Omentum-based structure and delivery system
CN105980567B (en)2013-07-192021-04-16孟山都技术有限公司 Compositions and methods for controlling Beetle
US9850496B2 (en)2013-07-192017-12-26Monsanto Technology LlcCompositions and methods for controlling Leptinotarsa
WO2015015489A1 (en)2013-07-302015-02-05Biolinerx Ltd.Antibody for treating diabetes and autoimmune diseases
CN105849117B (en)2013-08-292017-12-12耶达研究及发展有限公司The selective depressant of the hypotypes of α 2 of Na, K ATP enzyme and the purposes for reducing intraocular pressure
IL228284A (en)2013-09-032016-12-29Technion Res & Dev FoundationImplants composed of cellular scaffolds and a vascular pedicle
US20160251410A1 (en)2013-09-032016-09-01Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Compositions and methods for expressing recombinant polypeptides
WO2015033344A1 (en)2013-09-052015-03-12Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods and kits for inhibiting pathogenicity of group a streptococcus (gas) or group g streptococcus (ggs)
WO2015037009A1 (en)2013-09-162015-03-19Plexicure Ltd.Isolated proteins capable of binding plexin-a4 and methods of producing and using same
ES2717446T3 (en)2013-09-172019-06-21Yeda Res & Dev Peptides derived from ERK and uses thereof
AU2014330807B2 (en)2013-10-012020-07-02Kadimastem Ltd.Directed differentiation of astrocytes from human pluripotent stem cells for use in drug screening and the treatment of Amyotrophic Lateral Sclerosis (ALS)
US20150158926A1 (en)2013-10-212015-06-11Opko Biologics, Ltd.Long-acting polypeptides and methods of producing and administering same
DK3060239T3 (en)2013-10-212020-08-03Opko Biologics Ltd LONG-TERM POLICPTIDES AND METHODS OF MANUFACTURE AND SUBMISSION
EP3060656A1 (en)2013-10-242016-08-31Yeda Research and Development Co., Ltd.Polynucleotides encoding brex system polypeptides and methods of using same
WO2015063768A1 (en)2013-10-312015-05-07Biokine Therapeutics Ltd.Methods of treating acute myeloid leukemia with a flt3 mutation
CN105849266A (en)2013-11-042016-08-10孟山都技术公司Compositions and methods for controlling arthropod parasite and pest infestations
EP3074044A2 (en)2013-11-282016-10-05Yeda Research and Development Co., Ltd.Synaptojanin-2 inhibitors and uses thereof
WO2015079411A1 (en)2013-11-282015-06-04Tel Hashomer Medical Research Infrastructure And Services Ltd.Rna polymerase i inhibitors and uses thereof
UA119253C2 (en)2013-12-102019-05-27Біолоджикс, Інк. METHOD FOR VARROA TREATMENT AND VEGETABLES
US10053712B2 (en)2013-12-102018-08-21Yeda Research And Development Co. Ltd.Use of enzymes which catalyze pyruvate synthesis from formate and acetyl-CoA and bacteria expressing same
MX368629B (en)2014-01-152019-10-08Monsanto Technology LlcMethods and compositions for weed control using epsps polynucleotides.
WO2015114633A1 (en)2014-01-302015-08-06Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd.Actin binding peptides and compositions comprising same for inhibiting angiogenes is and treating medical conditions associated with same
CN106470699A (en)2014-02-032017-03-01耶路撒冷希伯来大学的益生研究开发有限公司 Use of a casein kinase I inhibitor to deplete stem cells
US10125365B2 (en)2014-02-052018-11-13Yeda Research And Development Co. Ltd.Micro-RNAs and compositions comprising same for the treatment and diagnosis of serotonin-, adrenalin-, noradrenalin-, glutamate-, and corticotropin-releasing hormone- associated medical conditions
WO2015118538A1 (en)2014-02-062015-08-13Yeda Research And Development Co. Ltd.Anti cd84 antibodies, compositions comprising same and uses thereof
WO2015118547A1 (en)2014-02-102015-08-13Protalix Ltd.Method of maintaining disease stability in a subject having gaucher's disease
BR112016018489A2 (en)2014-02-112017-08-08Brainstorm Cell Therapeutics Ltd MESENCHYMAL STEM CELL METHOD OF QUALIFICATION, ISOLATED POPULATION OF MESENCHYMAL STEM CELLS, METHOD OF TREATMENT OF AN IMMUNE OR INFLAMMATORY DISEASE, AND USE OF MESENCHYMAL STEM CELLS
CN106255882A (en)2014-03-032016-12-21耶路撒冷希伯来大学伊森姆研究发展公司For the method and apparatus detecting Pseudomonas aeruginosa
EP2923709A1 (en)2014-03-282015-09-30Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Multi-component-multistage malaria vaccine
CN110506752B (en)2014-04-012022-02-18孟山都技术公司Compositions and methods for controlling insect pests
WO2015155777A1 (en)2014-04-102015-10-15Bonus Therapeutics Ltd.Bone repair compositions
SI4026917T1 (en)2014-04-142024-05-31Yissum Research And Development Company Of The Hebrew University Of Jerusalem Ltd.A method and kit for determining the death of cells or tissue or the tissue or cell origin of dna by dna methylation analysis
US10590467B2 (en)2014-04-172020-03-17Yeda Research And Development Co. Ltd.Methods and kits for analyzing DNA binding moieties attached to DNA
US11427647B2 (en)2014-04-272022-08-30Famewave Ltd.Polynucleotides encoding humanized antibodies against CEACAM1
WO2015166484A1 (en)2014-04-272015-11-05Ccam Therapeutics Ltd.Humanized antibodies against ceacam1
US20160263166A1 (en)2014-04-282016-09-15Yeda Research And Development Co., Ltd.Microbiome response to agents
EP3140401A2 (en)2014-05-042017-03-15Forrest Innovations Ltd.Compositions for mosquito control and uses of same
WO2015177800A2 (en)2014-05-222015-11-26Yeda Research And Development Co. Ltd.Recombinant microorganisms capable of carbon fixation
EP3149155B1 (en)2014-06-022020-09-23Kadimastem Ltd.Methods of inducing myelination and maturation of oligodendrocytes
US20170253881A1 (en)2014-06-022017-09-07Technion Research & Development Foundation LimitedCompositions and methods of selectively inhibiting irp1 and treating inflammation
AU2015280252A1 (en)2014-06-232017-01-12Monsanto Technology LlcCompositions and methods for regulating gene expression via RNA interference
US20170183376A1 (en)2014-06-242017-06-29Insight Biopharmaceuticals Ltd.Methods of purifying antibodies
EP3161480B1 (en)2014-06-252020-02-12Tel HaShomer Medical Research Infrastructure and Services Ltd.Identification of cancer stem cell markers and use of same for diagnosis and treatment
US11807857B2 (en)2014-06-252023-11-07Monsanto Technology LlcMethods and compositions for delivering nucleic acids to plant cells and regulating gene expression
WO2015198326A1 (en)2014-06-262015-12-30Ramot At Tel-Aviv University Ltd.Liposomal formulations for delivery of nucleic acids
WO2016005985A2 (en)2014-07-092016-01-14Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method for reprogramming cells
BR112017000710B1 (en)2014-07-152024-02-27Yissum Research Development Company Of The Hebrew University Of Jerusalem ISOLATED POLYPEPTIDE, COMPOSITION OF MATTER, AND, USE OF THE ISOLATED POLYPEPTIDE OR COMPOSITION OF MATTER
EP3172340B1 (en)2014-07-212019-02-20Novellusdx Ltd.Methods for determining drug response of patient specific mutations
JP6837428B2 (en)2014-07-212021-03-10ノベルラスディクス リミテッド Methods and systems for determining the carcinogenicity index of patient-specific mutations
US10378012B2 (en)2014-07-292019-08-13Monsanto Technology LlcCompositions and methods for controlling insect pests
JP2017525351A (en)2014-07-302017-09-07イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ．Ｌｔｄ． Culture medium for pluripotent stem cells
US10303846B2 (en)2014-08-142019-05-28Memed Diagnostics Ltd.Computational analysis of biological data using manifold and a hyperplane
WO2016030899A1 (en)2014-08-282016-03-03Yeda Research And Development Co. Ltd.Methods of treating amyotrophic lateral scleroses
JP2017534574A (en)2014-09-082017-11-24イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ．Ｌｔｄ． Compositions and methods for treating cancer resistant to tyrosine kinase inhibitors (TKI)
WO2016038609A1 (en)2014-09-082016-03-17Yeda Research And Development Co. Ltd.Anti-her3 antibodies and uses of same
EP2992895A1 (en)2014-09-082016-03-09Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Three-component-multistage malaria vaccine
IL287789B2 (en)2014-09-112024-05-01The State Of Israel Ministry Of Agriculture & Rural Development Agricultural Res Organization Aro VoMethods of producing mogrosides and compositions comprising same and uses thereof
IL234638A0 (en)2014-09-142014-12-02Yeda Res & DevNmda receptor antagonists for treating gaucher disease
EP3230453B1 (en)2014-09-212020-05-20Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.Downregulating mir-132 for the treatment of lipid related disorders
US10093989B2 (en)2014-10-202018-10-09Gen-Probe IncorporatedRed blood cell lysis solution
WO2016075697A1 (en)2014-11-132016-05-19Enzootic Holdings Ltd.Functional sex-reversal of decapod crustacean females
CA2967233A1 (en)2014-11-172016-05-26Yeda Research And Development Co. Ltd.Method of analyzing microbiome
US20180042994A1 (en)2014-11-172018-02-15Yeda Research And Development Co. Ltd.Methods of treating diseases related to mitochondrial function
EP3221455B1 (en)2014-11-202020-08-12Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.Compositions and methods for producing polypeptides with a modified glycosylation pattern in plant cells
CN107208070B (en)2014-11-262021-09-07技术创新动力基金（以色列）有限合伙公司Targeted elimination of bacterial genes
US10883111B2 (en)2014-11-272021-01-05Danziger Innovations Ltd.Nucleic acid constructs for genome editing
WO2016092555A2 (en)2014-12-112016-06-16Yeda Research And Development Co. Ltd.Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
US20170269081A1 (en)2014-12-112017-09-21Memed Diagnostics Ltd.Marker combinations for diagnosing infections and methods of use thereof
WO2016103269A1 (en)2014-12-232016-06-30Ramot At Tel-Aviv University Ltd.Populations of neural progenitor cells and methods of producing and using same
WO2016108239A1 (en)2014-12-302016-07-07Cell Cure Neurosciences Ltd.Rpe cell populations and methods of generating same
EP3240890B1 (en)2014-12-302021-06-16Cell Cure Neurosciences Ltd.Assessing retinal pigment epithelial cell populations
EA201791518A1 (en)2014-12-302017-10-31Селл Кьюр Нейросайансес Лтд. METHODS TO TREAT DISEASES OF THE RETAIL
CA2970216A1 (en)2015-01-042016-07-07Protalix Ltd.Modified dnase and uses thereof
WO2016116935A1 (en)2015-01-212016-07-28Yeda Research And Development Co. Ltd.Use of rasa2 as a prognostic and therapeutic marker for melanoma
MX395326B (en)2015-01-222025-03-25Monsanto Technology Llc COMPOSITIONS AND METHODS FOR CONTROLLING LEPTINOTARSA.
US20180345047A1 (en)2015-02-262018-12-06Yeda Research And Development Co. Ltd.Method of promoting hair growth
WO2016142948A1 (en)2015-03-112016-09-15Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Decoy oligonucleotides for the treatment of diseases
IL237852A0 (en)2015-03-192016-03-24Yeda Res & DevAnti amphiregulin antibodies, compositions comprising same and uses thereof
EP4218771A1 (en)2015-03-272023-08-02Yeda Research and Development Co. LtdMethods of treating motor neuron diseases
ES2904573T3 (en)2015-03-272022-04-05Univ Southern California LHR-directed T cell therapy for the treatment of solid tumors
JP2018511325A (en)2015-03-312018-04-26イェダ リサーチ アンド ディベロップメント カンパニー リミテッドＹｅｄａ Ｒｅｓｅａｒｃｈ Ａｎｄ Ｄｅｖｅｌｏｐｍｅｎｔ Ｃｏ．Ｌｔｄ． Glutamate oxaloacetate transaminase 1 (GOT1), its preparation and production method and use thereof
US10960035B2 (en)2015-04-012021-03-30The State of Israel, Ministry of Agriculture & Rural Development, Agricultural Research Organization (ARO) (Voleaui Center)Erodium crassifolium L'Her plant extracts and uses thereof
WO2016162870A1 (en)2015-04-072016-10-13Ilana NathanCompositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
EP3081575A1 (en)2015-04-122016-10-19Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.Anti-plasmodium parasite antibodies
WO2016174674A1 (en)2015-04-272016-11-03The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterEgr1 targeting molecules for the treatment of inflammatory and hyperproliferative conditions
US10674732B2 (en)2015-04-292020-06-09The State Of Israel, Ministry Of Agriculture & Rural Development Agricultural Research OrganizationAnti-phytopathogenic compositions
US20190031759A1 (en)2015-04-302019-01-31Technion Research & Development Foundation LimitedChimeric antigen receptors and methods of their use
EP3292219B9 (en)2015-05-042022-05-18Ramot at Tel-Aviv University Ltd.Methods and kits for fragmenting dna
US20180161300A1 (en)2015-05-112018-06-14Yeda Research And Development Co., Ltd.Citrin inhibitors for the treatment of cancer
EP3298141A4 (en)2015-05-172019-01-09The Medical Research, Infrastructure, And Health Services Fund Of The Tel Aviv Medical Center COMPOSITIONS AND METHODS OF TREATING CANCER
WO2016185457A1 (en)2015-05-192016-11-24Yeda Research And Development Co. Ltd.Methods of promoting lymphangiogenesis
EP3297680A2 (en)2015-05-202018-03-28Yeda Research and Development Co. LtdMethod of targeting senescent cells
US20180140648A1 (en)2015-05-212018-05-24Yeda Research And Development Co. Ltd.Bacterial populations for promoting health
CA2987706A1 (en)2015-05-292016-12-08Opko Biologics Ltd.Pegylated oxyntomodulin variants
WO2016196738A1 (en)2015-06-022016-12-08Monsanto Technology LlcCompositions and methods for delivery of a polynucleotide into a plant
WO2016196782A1 (en)2015-06-032016-12-08Monsanto Technology LlcMethods and compositions for introducing nucleic acids into plants
AU2016270474A1 (en)2015-06-042018-01-04University Of Southern CaliforniaLym-1 and Lym-2 targeted CAR cell immunotherapy
NL2014935B1 (en)2015-06-082017-02-03Applied Immune Tech LtdT cell receptor like antibodies having fine specificity.
EP4026563A1 (en)2015-06-182022-07-13Yeda Research and Development Co. LtdConditioning protocols and use of same for tissue regeneration
WO2016203476A1 (en)2015-06-182016-12-22Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods and compositions for diagnosing and treating urothelial cancer
WO2016203482A2 (en)2015-06-192016-12-22Opko Biologics Ltd.Long-acting coagulation factors and methods of producing same
US10682390B2 (en)2015-07-162020-06-16Biokine Therapeutics Ltd.Compositions and methods for treating cancer
US11179448B2 (en)2015-07-162021-11-23Yeda Research And Development Co. Ltd.Genetically modified anti-third party central memory T cells and use of same in immunotherapy
US10668094B2 (en)2015-07-192020-06-02Yeda Research And Development Co. Ltd.Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure
EP3324754B1 (en)2015-07-222022-09-07Phytopharma International Ltd.Bee-ingestible compositions, methods of using same for producing honey and honey produced thereby
WO2017017686A1 (en)2015-07-292017-02-02Hadasit Medical Research Services And Development Ltd.Large scale production of retinal pigment epithelial cells
EP3331546B1 (en)2015-08-032023-10-04Biokine Therapeutics Ltd.Cxcr4 inhibitor for the treatment of cancer
US20180237774A1 (en)2015-08-042018-08-23Yeda Research And Development Co. Ltd.Methods of screening for riboswitches and attenuators
AU2016303631B2 (en)2015-08-052022-07-28Cell Cure Neurosciences Ltd.Preparation of photoreceptors for the treatment of retinal diseases
CA2993912A1 (en)2015-08-052017-02-09Cell Cure Neurosciences Ltd.Preparation of retinal pigment epithelium cells
US10639350B2 (en)2015-08-102020-05-05The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterMethods and pharmaceutical compositions for improving wound healing using CD24
EP3334831A1 (en)2015-08-132018-06-20Forrest Innovations Ltd.Formulations and compositions for delivery of nucleic acids to plant cells
WO2017033188A1 (en)2015-08-242017-03-02Yeda Research And Development Co. Ltd.Algal oil and biofuel and methods of producing same
US10765706B2 (en)2015-09-032020-09-08University Of South FloridaMethod of stem cell delivery into the brain during chronic disease using blood brain barrier permeabilizers
WO2017042816A1 (en)2015-09-102017-03-16Yeda Research And Development Co. Ltd.Ablation of perforin positive dendritic cells in cancer treatment
EP3365376A1 (en)2015-10-252018-08-29Yeda Research and Development Co., Ltd.Antibodies targeting quiescin sulfhydryl oxidase (qsox1) and uses of same
HUE070900T2 (en)2015-10-262025-07-28Cell Cure Neurosciences LtdPreparation of retinal pigment epithelium cells
JP7078538B2 (en)2015-10-272022-05-31ジェイ ファーマ、インコーポレイティッド A composition comprising cannabidiol and a second therapeutic agent for the treatment of cancer
IL242380A0 (en)2015-10-292016-02-01Yeda Res & DevA method of inducing cardiomyocytes proliferation and treating heart diseases
US20180303974A1 (en)2015-11-032018-10-25Ariel-University Research And Development Company Ltd.Compositions for regeneration and repair of neural tissue
US20180327855A1 (en)2015-11-112018-11-15Ramot At Tel-Aviv University Ltd.Methods of detecting 5-hydroxymethylcytosine and diagnosing of cancer
EP4231015B1 (en)2015-11-302024-10-30Kadimastem Ltd.Methods for differentiating and purifying pancreatic endocrine cells
EP3176183A1 (en)2015-12-022017-06-07Yeda Research and Development Co. LtdCompositions and methods for treating cancer not resistant to a tyrosine kinase inhibitor (tki)
WO2017103930A1 (en)2015-12-162017-06-22Ramot At Tel-Aviv University Ltd.Particles comprising decellularized omentum
WO2017115367A1 (en)2015-12-282017-07-06The National Institute for Biotechnology in the Negev Ltd.Composition and method for treating amyotrophic lateral sclerosis
CN108697907A (en)2016-01-062018-10-23耶达研究及发展有限公司Composition for treating malignant disease, autoimmune disease and inflammatory disease and method
EP3403091B1 (en)2016-01-112021-12-22Technion Research & Development Foundation LimitedMethods of determining prognosis of sepsis and treating same
US11839195B2 (en)2016-01-212023-12-12The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (Aro) (Volcani Center)Parthenocarpic tomato plants with loss of function mutation in an AGL6 gene and methods of producing same
IL243839B (en)2016-01-282018-01-31Sp Nano LtdConductive yarn
IL243838A (en)2016-01-282017-07-31Sp Nano LtdComposition comprising sp1 and carbon based nanoparticles and uses thereof
WO2017130205A1 (en)2016-01-312017-08-03Hadasit Medical Research Services And Development Ltd.Autosomal-identical pluripotent stem cell populations having non-identical sex chromosomal composition and uses thereof
WO2017134671A1 (en)2016-02-042017-08-10Yeda Research And Development Co. Ltd.Peptides and use of same in the treatment of diseases, disorders or conditions associated with a mutant p53
WO2017138007A1 (en)2016-02-142017-08-17Yeda Research And Development Co. Ltd. At The Weizmann Institute Of ScienceMicrobiome-based diagnosis, prediction and treatment of relapsing obesity
WO2017138008A2 (en)2016-02-142017-08-17Yeda Research And Development Co. Ltd.Methods of modulating protein exocytosis and uses of same in therapy
KR20180111987A (en)2016-02-162018-10-11이슘 리서치 디벨롭먼트 컴퍼니 오브 더 히브루 유니버시티 오브 예루살렘 엘티디. Cyanobacteria and non-protein phenylalanine analogs for plant growth inhibition
IL260983B (en)2016-02-192022-07-01Genisphere Llc Nucleic acid carriers and methods of medical use
US11053476B2 (en)2016-02-232021-07-06Exostem Biotec Ltd.Generation of cancer stem cells and use thereof
BR112018067522A2 (en)2016-03-012019-02-05Univ Of Rijeka Faculty Of Medicine human poliovirus receptor (pvr) specific antibodies
EP3423589B1 (en)2016-03-032021-07-21Memed Diagnostics Ltd.Analyzing rna for diagnosing infection type
US20190216891A1 (en)2016-03-062019-07-18Yeda Research And Development Co., Ltd.Method for modulating myelination
IL244649A0 (en)2016-03-172016-06-30Yeda Res & DevMethods of isolating barrel-like proteases and identifying peptides processed thereby
WO2017175228A1 (en)2016-04-062017-10-12Technion Research & Development Foundation LimitedInfiltrating immune cell proportions predict anti-tnf response in colon biopsies
US10421785B2 (en)2016-04-112019-09-24Bar-Ilan UniversityDelta receptor agonist peptides and use thereof
WO2017189746A1 (en)2016-04-272017-11-02Gen-Probe IncorporatedBlood cell lysis reagent
ES2886627T3 (en)2016-05-222021-12-20Yeda Res & Dev Methods of using lung cells for transplantation and tolerance induction
IL245861A0 (en)2016-05-252016-09-04Yeda Res & DevUse of agents for treating drug resistant tumors
WO2017208247A1 (en)2016-06-022017-12-07Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Assay for the removal of methyl-cytosine residues from dna
US11820833B2 (en)2016-06-052023-11-21Tel Hashomer Medical Research Infrastructure And Services Ltd.Peptides that inhibit binding of EPCR to its ligand to treat inflammation
EP3468610A1 (en)2016-06-092019-04-17OPKO Biologics Ltd.Long-acting oxyntomodulin formulation and methods of producing and administering same
EP3472342A1 (en)2016-06-192019-04-24Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.Screening for chemotherapy resistance in human haploid cells
MX2019000022A (en)2016-06-272019-09-18Yeda Res & Dev VETO CELLS GENERATED FROM MEMORY T LYMPHOCYTES.
US11340223B2 (en)2016-07-102022-05-24Memed Diagnostics Ltd.Early diagnosis of infections
EP4141448A1 (en)2016-07-102023-03-01MeMed Diagnostics Ltd.Protein signatures for distinguishing between bacterial and viral infections
IL291373B2 (en)2016-07-112023-10-01Yissum Res Dev Co Of Hebrew Univ Jerusalem LtdSystems and methods for growing cells in vitro
CA3030533A1 (en)2016-07-112018-01-18Oren HERSHKOVITZLong-acting coagulation factor vii and methods of producing same
IL246722A0 (en)2016-07-112016-09-29Yeda Res & Dev Combined treatment to increase endogenous synthesis of nitric oxide
IL264205B2 (en)2016-07-112023-12-01Bonus Therapeutics LtdCell compositions for tissue regeneration
ES3034904T3 (en)2016-07-182025-08-27Univ RamotModular platform for targeted therapeutics
WO2018020489A1 (en)2016-07-242018-02-01Yeda Research And Development Co. Ltd.Methods and kits for analyzing dna binding moieties attached to dna
WO2018029682A1 (en)2016-08-082018-02-15Ramot At Tel-Aviv University Ltd.Bacterial systems for analyzing ubiquitylated polypeptides
WO2018029693A1 (en)2016-08-102018-02-15Ramot At Tel-Aviv University Ltd.Analysis of methylation status and copy number
CN109844532B (en)2016-08-102022-06-17米密德诊断学有限公司 Systems and methods for analyzing biological data
CN109843305B (en)2016-08-142023-03-10雷蒙特亚特特拉维夫大学有限公司Mesenchymal cell-derived exosomes for treating neurological disorders
IL247368A0 (en)2016-08-182016-11-30Yeda Res & DevDiagnostic and therapeutic uses of exosomes
WO2018037416A1 (en)2016-08-252018-03-01Yeda Research And Development Co. Ltd.Methods and compositions for treating autoimmune diseases
AU2017319783B2 (en)2016-08-282021-12-23The State of Israel, Ministry of Agriculture & Rural Development Agricultural Research Organization (ARO) (Volcani Center)Method of controlling fungal infections in plants
JP2020501506A (en)2016-09-072020-01-23イッサム リサーチ デベロップメント カンパニー オブ ザ ヘブリュー ユニバーシティー オブ エルサレム エルティーディー． Anti-NKp46 antibody and therapeutic use thereof
EP3512943B1 (en)2016-09-142023-04-12Yeda Research and Development Co. Ltd.Crisp-seq, an integrated method for massively parallel single cell rna-seq and crispr pooled screens
EP3519833B1 (en)2016-09-292024-08-14MeMed Diagnostics Ltd.Methods of prognosis and treatment
IL248468A0 (en)2016-10-132017-01-31Technion Res & Dev Foundation Use of caspase-3 inhibitors and caspase-3 activators in the preparation of medical preparations for cancer treatment and wound healing
IL248385A0 (en)2016-10-182017-02-01Yeda Res & DevTreatment of a circadian rhythm disorder
US20190359956A1 (en)2016-11-102019-11-28Yeda Research And Development Co. Ltd.Phosphotriesterases for treating or preventing organophosphate exposure associated damage
WO2018096547A1 (en)2016-11-282018-05-31Yeda Research And Development Co. Ltd.Isolated polynucleotides and polypeptides and methods of using same for expressing an expression product of interest
US20190343782A1 (en)2016-11-302019-11-14Yeda Research And Development Co. Ltd.Methods of treating liver toxicity and disorders
CA3026989C (en)2016-12-012023-07-11Ramot At Tel-Aviv University Ltd.Combined treatment for nerve injuries
WO2018134824A1 (en)2017-01-182018-07-26Yeda Research And Development Co. Ltd.Genetically modified veto cells and use of same in immunotherapy
CN110234997B (en)2017-01-252023-06-16St创新诊断有限公司 Methods of Diagnosing Malignant Diseases
IL250479A0 (en)2017-02-062017-03-30Sorek RotemIsolated cells genetically modified to express a disarm system having an anti-phage activity and methods of producing same
US12281328B2 (en)2017-02-082025-04-22Hadasit Medical Research Services And Development Ltd.Photoreceptor cells for the treatment of retinal diseases
IL250916A0 (en)2017-03-022017-06-29Geiger BenjaminMethods of culturing t cells and uses of same
WO2018167780A1 (en)2017-03-122018-09-20Yeda Research And Development Co. Ltd.Methods of prognosing and treating cancer
US20200150125A1 (en)2017-03-122020-05-14Yeda Research And Development Co., Ltd.Methods of diagnosing and prognosing cancer
BR112019019190A2 (en)2017-03-162020-04-22Lineage Cell Therapeutics Inc methods for treating diseases of the retina
FI3607050T3 (en)2017-04-052023-11-20Yeda Res & Dev EX VIVO CULTURE SYSTEM AND METHODS FOR USING IT
IL252151A0 (en)2017-05-072017-07-31Fainzilber MichaelMethods of treating psychiatric stress disorders
US12091445B2 (en)2017-05-102024-09-17Ariel Scientific Innovations Ltd.Methods of purifying antibodies
WO2018216006A1 (en)2017-05-212018-11-29The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterCombination of markers for diagnosing cancer
US20200172604A1 (en)2017-05-232020-06-04Technion Research & Development Foundation LimitedAgents which inhibit gads dimerization and methods of use thereof
EP3630973A1 (en)2017-05-312020-04-08Tropic Biosciences UK LimitedMethods of selecting cells comprising genome editing events
GB201708665D0 (en)2017-05-312017-07-12Tropic Biosciences Uk LtdCompositions and methods for increasing extractability of solids from coffee beans
GB201708662D0 (en)2017-05-312017-07-12Tropic Biosciences Uk LtdCompositions and methods for increasing shelf-life of banana
WO2018229764A1 (en)2017-06-132018-12-20Yeda Research And Development Co. Ltd.Treatment of advanced or progressive multiple sclerosis
EP4403646A3 (en)2017-07-132025-01-08Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.Dna targets as tissue-specific methylation markers
WO2019012544A1 (en)2017-07-132019-01-17Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Dual-probe digital droplet pcr strategy for specific detection of tissue-specific circulating dna molecules
EP3652342A1 (en)2017-07-132020-05-20Yissum Research and Development Company of the Hebrew University of Jerusalem Ltd.Detecting tissue-specific dna
IL253642A0 (en)2017-07-242017-09-28Seger RonyCombination therapy for the treatment of cancer
EP3665283A4 (en)2017-08-082021-04-21Technology Innovation Momentum Fund (Israel) Limited Partnership CHLORAMPHENICOL RESISTANT SPLIT PROTEIN AND USES THEREOF
IL253984A0 (en)2017-08-142017-09-28Yeda Res & DevImmunotherapy against transferrin receptor 1 (tfr1)-tropic arenaviruses
WO2019038761A1 (en)2017-08-212019-02-28Savicell Diagnostic Ltd.Methods of diagnosing and treating lung cancer
WO2019038771A1 (en)2017-08-232019-02-28Technion Research & Development Foundation LimitedCompositions and methods for improving alcohol tolerance in yeast
US20200270604A1 (en)2017-09-192020-08-27Tropic Biosciences UK LimitedModifying the specificity of non-coding rna molecules for silencing gene expression in eukaryotic cells
CN111315212B (en)2017-09-192022-06-14以色列农业和农村发展部农业研究组织(范卡尼中心) genome-edited bird
WO2019082184A1 (en)2017-10-242019-05-02Elani DaliaMethods of treating an ischemic disease
AU2018364630A1 (en)2017-11-092020-05-21Pinteon Therapeutics Inc.Methods and compositions for the generation and use of humanized conformation-specific phosphorylated tau antibodies
IL255664A0 (en)2017-11-142017-12-31Shachar IditHematopoietic stem cells with improved properties
WO2019106667A1 (en)2017-11-292019-06-06Weedout Ltd.Compositions, kits and methods for controlling weed of the amaranthus genus
EP3717032B1 (en)2017-11-292023-02-15Ramot at Tel-Aviv University Ltd.Methods of preventing or treating neurogenic shock
WO2019106680A1 (en)2017-12-032019-06-06Yeda Research And Development Co. Ltd.Treatment of an ischemic heart disease
EP3723785A1 (en)2017-12-172020-10-21Yeda Research and Development Co. LtdCop9 signalosome (csn) complex modulators and uses thereof
WO2019130313A1 (en)2017-12-282019-07-04Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method to reproduce circadian rhythms on a microfluidic chip
IL257225A (en)2018-01-292018-04-09Yeda Res & DevTreatment of sarcoma
US20210112739A1 (en)2018-01-292021-04-22Lavie Bio LtdPlant microbial preparations, compositions and formulations comprising same and uses thereof
IL257269A (en)2018-01-312018-04-09Olender TsviyaEndoplasmic reticulum targeting signal
EP3749689A1 (en)2018-02-082020-12-16Yeda Research and Development Co. LtdInhibitors of the 20s proteasome
WO2019155465A1 (en)2018-02-082019-08-15Yeda Research And Development Co. Ltd.Methods of identifying and using agents for treating diseases associated with intestinal barrier dysfunction
EP3755340A4 (en)2018-02-232021-11-17Carmel-Haifa University Economic Corporation Ltd. METHOD OF TREATMENT FOR MEMORY DISORDERS AND COGNITIVE DYSFUNCTION
WO2019167047A1 (en)2018-02-282019-09-06The Medical Research, Infrastructure and Health Services Fund of the Tel Aviv Medical CenterMethods of diagnosing and treating bladder cancer
WO2019175869A1 (en)2018-03-122019-09-19Yeda Research And Development Co. LtdTreatment of a heart disease
JP7518498B2 (en)2018-03-292024-07-18テクニオン・リサーチ・アンド・ディベロップメント・ファウンデーション・リミテッド Vesicles containing pten inhibitors and uses thereof
WO2019186569A1 (en)2018-03-292019-10-03Yeda Research And Development Co. Ltd.Use of electric field gradients to control gene expression
IL258467A (en)2018-03-292018-07-04Ilana Kolodkin GalMethods of disrupting a biofilm and/or preventing formation of same
GB201807192D0 (en)2018-05-012018-06-13Tropic Biosciences Uk LtdCompositions and methods for reducing caffeine content in coffee beans
WO2019220441A1 (en)2018-05-152019-11-21Hadasit Medical Research Services And Development Ltd.Compositions and methods for treating cancer resistant to an anti-cancer agent
IL259392A (en)2018-05-152018-08-01Yeda Res & Dev Vaccination with cancer neo-antigens
EP3801614A1 (en)2018-05-272021-04-14BioLineRx Ltd.Agi-134 combined with a checkpoint inhibitor for the treatment of solid tumors
CN112424365A (en)2018-06-072021-02-26以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心Nucleic acid constructs and methods of use thereof
CN112384063A (en)2018-06-072021-02-19以色列国家农业部、农村发展农业研究组织·沃尔卡尼中心Methods for regeneration and transformation of cannabis
WO2020003311A1 (en)2018-06-252020-01-02Yeda Research And Development Co. Ltd.Systems and methods for increasing efficiency of genome editing
AU2019297677B2 (en)2018-07-042024-11-07Ukko Inc.Methods of de-epitoping wheat proteins and use of same for the treatment of celiac disease
US20210269860A1 (en)2018-07-082021-09-02Yeda Research And Development Co. Ltd.Person-specific assessment of probiotics responsiveness
KR20210045397A (en)2018-07-112021-04-26이뮤니티 파르마 엘티디. Peptide compounds and therapeutic uses thereof
CA3104780A1 (en)2018-07-112020-01-16Kahr Medical Ltd.Sirpalpha-4-1bbl variant fusion protein and methods of use thereof
CN112823208A (en)2018-07-312021-05-18科弗朗有限公司Tobacco transgenic events and methods for detecting and using tobacco transgenic events
IL261156A (en)2018-08-142020-02-27Fass DeborahChimeric quiescin sulfhydryl oxidase (qsox1) antibodies and uses of same
JP2021535100A (en)2018-08-242021-12-16イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. Methods and Treatments for Modulating M2 Macrophage Polarization
EP3852759A2 (en)2018-09-202021-07-28Yeda Research and Development Co. LtdMethods of treating amyotrophic lateral sclerosis
WO2020065647A1 (en)2018-09-252020-04-02Biolinerx Ltd.Methods of selecting treatment for cxcr4-associated cancer
IL262658A (en)2018-10-282020-04-30Memorial Sloan Kettering Cancer CenterPrevention of age related clonal hematopoiesis and diseases associated therewith
IL263184A (en)2018-11-212020-05-31Yarden YosefMethod of treating cancer and compositions for same
WO2020152686A1 (en)2019-01-232020-07-30Yeda Research And Development Co. Ltd.Culture media for pluripotent stem cells
IL264768A (en)2019-02-102020-08-31Sagi IritAnti-matrix metalloproteinase 7 (mmp-7) inhibitory antibody and uses thereof
IL264854A (en)2019-02-142020-08-31Bahat AnatSpt5 inhibitors and methods of use thereof
WO2020170239A1 (en)2019-02-212020-08-27Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Methods of generating organoids for high throughput screening of drugs
JP2022521010A (en)2019-02-212022-04-04イッスム・リサーチ・デベロプメント・カムパニー・オブ・ザ・ヘブリュー・ユニバシティー・オブ・エルサレム リミテッド Methods for reducing drug-induced nephrotoxicity
KR20210137499A (en)2019-03-052021-11-17더 스테이트 오브 이스라엘, 미니스트리 오브 애그리컬처 & 루럴 디벨로프먼트, 애그리컬처럴 리서치 오거니제이션, (에이.알.오.), 볼카니 센터 Genome-Editing Birds
WO2020185763A1 (en)2019-03-112020-09-17Memorial Sloan Kettering Cancer CenterCd22 antibodies and methods of using the same
GB201903521D0 (en)2019-03-142019-05-01Tropic Biosciences Uk LtdNo title
GB201903520D0 (en)2019-03-142019-05-01Tropic Biosciences Uk LtdModifying the specificity of non-coding rna molecules for silencing genes in eukaryotic cells
GB201903519D0 (en)2019-03-142019-05-01Tropic Biosciences Uk LtdIntroducing silencing activity to dysfunctional rna molecules and modifying their specificity against a gene of interest
IL265486A (en)2019-03-192020-09-30Yeda Res & DevBistable type ii opsins and uses thereof
WO2020194317A1 (en)2019-03-282020-10-01Yeda Research And Development Co. Ltd.Method of treating lipid-related disorders
WO2020202142A2 (en)2019-03-312020-10-08Yeda Research And Development Co. Ltd.Anti-viral and anti-tumoral compounds
IL266433B (en)2019-05-022020-11-30Sagi IritCompositions comprising the propeptide of lysyl oxidase and uses thereof
EP3969619A1 (en)2019-05-132022-03-23Yeda Research and Development Co. LtdCell-free mirna biomarkers for prognosis and diagnosis of neurodegenerative diseases
IL266728B (en)2019-05-192020-11-30Yeda Res & DevIdentification of recurrent mutated neopeptides
AU2020279080A1 (en)2019-05-222022-01-20Hadasit Medical Research Services And Development Ltd.Methods of culturing human pluripotent cells
EP3976646A4 (en)2019-05-282023-04-19Shanghaitech University COMPOSITION AND METHODS OF TREATMENT OF ECTODERMAL DYSPLASIA 2, CLOUSTON TYPE
CA3141995A1 (en)2019-06-122020-12-17Hadasit Medical Research Services And Development Ltd.Methods of generating oligodendrocytes
EP3983540A1 (en)2019-06-162022-04-20Yeda Research and Development Co. LtdMethod for stabilizing intracellular rna
WO2020261281A1 (en)2019-06-272020-12-30Ramot At Tel-Aviv University Ltd.Semaphorin 3a antibodies and uses thereof
JP2022538647A (en)2019-07-042022-09-05ウッコ インコーポレイテッド De-epitoped alpha gliadin and its use for the management of celiac disease and gluten sensitivity
AU2020311636A1 (en)2019-07-112022-03-03Kahr Medical Ltd.Heterodimers and methods of use thereof
EP3999851A4 (en)2019-07-162023-04-12Ramot at Tel-Aviv University Ltd.Compositions and methods for the treatment of tuberculosis
IL268111A (en)2019-07-162021-01-31Fainzilber MichaelMethods of treating pain
EP4004548A1 (en)2019-07-292022-06-01Yeda Research and Development Co. LtdMethods of treating and diagnosing lung cancer
CA3148950A1 (en)2019-07-302021-02-04The State Of Israel, Ministry Of Agriculture & Rural Development, Agricultural Research Organization (A.R.O.), Volcani CenterMethods of controlling cannabinoid synthesis in plants or cells and plants and cells produced thereby
EP4014046A1 (en)2019-08-122022-06-22Yeda Research and Development Co. LtdDna repair blood test for predicting response of lung cancer patients to immunotherapy
US20240140988A1 (en)2019-08-222024-05-02Ariel Scientific Innovations Ltd.Scaled-up methods for purifying antibodies
EP4021463A1 (en)2019-08-272022-07-06Yeda Research and Development Co. LtdTreatment of bacterial vaginosis
WO2021048852A1 (en)2019-09-112021-03-18Yeda Research And Development Co. Ltd.Methods of treating breast cancer
IL269674B (en)2019-09-252020-08-31Roy Bar ZivAssembly of protein complexes on a chip
IL270306A (en)2019-10-302021-05-31Yeda Res & DevPrevention and treatment of pre-myeloid and myeloid malignancies
US20240117386A1 (en)2019-10-312024-04-11Yeda Research And Development Co. Ltd.Engineered autotrophic bacteria for co2 conversion to organic materials
BR112022009087A2 (en)2019-11-112022-07-26Ibi Ag Innovative Bio Insecticides Ltd NANOBODY FOR INSECT CONTROL AND USES THEREOF
AU2019474716A1 (en)2019-11-192022-07-07Protalix Ltd.Removal of constructs from transformed cells
IL270800A (en)2019-11-202021-05-31Yeda Res & DevMethod of treating alzheimer’s disease
EP4077731A1 (en)2019-12-222022-10-26Yeda Research and Development Co. LtdDiagnosis of frontotemporal dementia
IL271656A (en)2019-12-222021-06-30Yeda Res & DevSystems and methods for identifying cells that have undergone genome editing
IL271778A (en)2019-12-312021-06-30Ichilov Tech LtdMethods of treating atopic dermatitis
WO2021137231A1 (en)2019-12-312021-07-08Kahr Medical Ltd.Methods of culturing t cells with a 4-1bbl fusion polypeptide and uses of same
US20230048361A1 (en)2019-12-312023-02-16Kahr Medical Ltd.Methods of culturing t cells and uses of same
IL272074B2 (en)2020-01-152024-12-01Immunity Pharma Ltd Peptide compounds and their use in methods of treating diseases
IL272194A (en)2020-01-222021-07-29Yeda Res & DevMultispecific antibodies for use in treating diseases
WO2021152584A1 (en)2020-01-282021-08-05Ariel Scientific Innovations Ltd.Methods of analyzing cell membranes
US20230094142A1 (en)2020-01-292023-03-30Memed Diagnostics Ltd.Methods of diagnosing and classifying viral infections
WO2021152586A1 (en)2020-01-302021-08-05Yeda Research And Development Co. Ltd.Methods of analyzing microbiome, immunoglobulin profile and physiological state
EP4096647A1 (en)2020-01-302022-12-07Yeda Research and Development Co. LtdTreating acute liver disease with tlr-mik inhibitors
IL272389A (en)2020-01-302021-08-31Yeda Res & DevArticles of manufacture comprising anti pd-l1 antibodies and their use in therapy
IL272390A (en)2020-01-302021-08-31Yeda Res & DevMethods of treating cancer
JP2023513334A (en)2020-02-092023-03-30エヌエルシー ファーマ リミテッド Rapid detection test for SARS-COV-2
IL272586A (en)2020-02-102021-08-31Yeda Res & DevMethod for analyzing cell clusters
WO2021173674A1 (en)2020-02-262021-09-02A2 Biotherapeutics, Inc.Polypeptides targeting mage-a3 peptide-mhc complexes and methods of use thereof
WO2021186431A1 (en)2020-03-162021-09-23Yeda Research And Development Co. Ltd.Peptide analogs and use of same in treating diseases, disorders or conditions associated with a mutant p53 protein
US20230132790A1 (en)2020-03-292023-05-04Yeda Research And Development Co. Ltd.Variants of beta-glucocerebrosidase for use in treating gaucher disease
WO2021199047A1 (en)2020-03-312021-10-07Biomuse Ltd.Bacteria for the prevention and treatment of smoke-induced lung damage
EP4133107A1 (en)2020-04-062023-02-15Yeda Research and Development Co. LtdMethods of diagnosing cancer and predicting responsiveness to therapy
WO2021205459A1 (en)2020-04-072021-10-14Ramot At Tel-Aviv University Ltd.Cannabidiol-containing compositions and uses thereof
WO2021209995A1 (en)2020-04-132021-10-21Exoprother Medical Ltd.Cell-derived vesicles comprising wild-type p53 protein for antiviral therapy
US20210322483A1 (en)2020-04-162021-10-21Ichilov Tech Ltd.Cell-derived particles presenting heterologous cd24 and use thereof in therapy
WO2021229577A1 (en)2020-05-122021-11-18Collplant Ltd.Collagen as a delivery tool for metal-based anti-viral agents
IL274811B (en)2020-05-202021-05-31Yeda Res & DevIndexing spatial information for a single-cell downstream applications
EP4521115A3 (en)2020-06-102025-06-11Ramot at Tel-Aviv University Ltd.Methods of detecting methylated cpg
AU2021294559A1 (en)2020-06-222023-02-23Ramot At Tel-Aviv University Ltd.Multi subunit protein modules, cells expressing same and uses thereof
US20230293530A1 (en)2020-06-242023-09-21Yeda Research And Development Co. Ltd.Agents for sensitizing solid tumors to treatment
IL276599A (en)2020-08-092022-03-01Yeda Res & DevMage-a1 specific t cell receptor and uses thereof
IL276627A (en)2020-08-102022-03-01Yeda Res & DevCompositions for diagnosis and treatment of coronavirus infections
WO2022038536A1 (en)2020-08-182022-02-24International Rice Research InstituteMethods of increasing outcrossing rates in gramineae
IL277488A (en)2020-09-212022-04-01Yeda Res & DevMethod for modulating weight
EP4217370A2 (en)2020-09-232023-08-02Yeda Research and Development Co. LtdMethods and compositions for treating coronaviral infections
IL277743A (en)2020-10-012022-04-01Yeda Res & DevMethod of diagnosing breast cancer
IL301914A (en)2020-10-052023-06-01Protalix Ltd Plant cells in which Dicer-like genes have been knocked out
JP2023545740A (en)2020-10-072023-10-31プロタリクス リミテッド Long-term active DNase
EP4228637A1 (en)2020-10-152023-08-23Yeda Research and Development Co. LtdMethod of treating myeloid malignancies
IL278401A (en)2020-10-292022-05-01Yeda Res & DevPolynucleotides for rna editing and methods of using same
US20230416750A1 (en)2020-11-092023-12-281E Therapeutics Ltd.Catalytic sequence based methods of treating or preventing bacterial infections
IL302707A (en)2020-11-262023-07-01Ukko Inc A subunit of glutenin that has been modified and has a high molecular weight and its uses
IL279559A (en)2020-12-172022-07-01Yeda Res & Dev Controlling the ubiquitination process of mlkl for disease treatment
KR20230126725A (en)2020-12-282023-08-301이 테라퓨틱스 엘티디. P21 mRNA target site for silencing
EP4267742A2 (en)2020-12-282023-11-011E Therapeutics, Ltd.P21 mrna targeting dnazymes
EP4274886A2 (en)2021-01-102023-11-15Supermeat the Essence of Meat Ltd.Pluripotent stem cell aggregates and microtissues obtained therefrom for the cultured meat industry
WO2022153286A1 (en)2021-01-142022-07-21Yeda Research And Development Co. Ltd.Methods of producing vitamin d
IL280340B (en)2021-01-212022-04-01Yeda Res & DevAntibodies, peptides and combinations of same for the treatment or prevention of coronavirus infection
EP4294428A1 (en)2021-02-182023-12-27Yeda Research and Development Co. LtdMethod of generating vaccines
JP2024506954A (en)2021-02-182024-02-15イェダ リサーチ アンド デベロップメント カンパニー リミテッド Genetically modified bacteria for vaccine production
IL281561A (en)2021-03-162022-10-01Yeda Res & Dev Methods and devices for growing mouse embryos outside the uterus
AU2022247325A1 (en)2021-03-302023-10-05Biomx Ltd.Pseudomonas bacteriophage and uses thereof
IL282188A (en)2021-04-082022-11-01Yeda Res & DevA combined use of ketamine and retigabine (ezogabine) for the treatment of psychiatric disorders
JP2024520907A (en)2021-05-122024-05-27バイオエムエックス・リミテッド Staphylococcal bacteriophages and uses thereof
IL283563A (en)2021-05-302022-12-01Yeda Res & DevAnti-microbial peptide (amp) signatures for diagnostics, stratification, and treatment of microbiome-associated disease
WO2022259242A1 (en)2021-06-062022-12-15Yeda Research And Development Co. Ltd.Combined treatment for cancer
CA3230677A1 (en)2021-06-132022-12-22Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd.Method for reprogramming human cells
JP2024530389A (en)2021-06-162024-08-21シードエックス テクノロジーズ インク How to Select Mattiola Seeds
NL2028466B1 (en)2021-06-162022-12-21Sakata Holland B VMethods of sorting matthiola seeds
JP2024524924A (en)2021-07-022024-07-09トロピック バイオサイエンシーズ ユーケー リミテッド Delaying or preventing browning in banana fruit
EP4373919A1 (en)2021-07-182024-05-29Gamida-Cell Ltd.Therapeutic nk cell populations
WO2023002492A1 (en)2021-07-222023-01-26Yeda Research And Development Co. Ltd.Codon optimization of nucleic acids
EP4380966A2 (en)2021-08-032024-06-12Genicity LimitedEngineered tcr complex and methods of using same
EP4130028A1 (en)2021-08-032023-02-08Rhazes Therapeutics LtdEngineered tcr complex and methods of using same
US20240358828A1 (en)2021-08-102024-10-31Gamida Cell Ltd.Engineered nk cells, methods of their production and uses thereof
GB202112865D0 (en)2021-09-092021-10-27Tropic Biosciences Uk LtdResistance to black sigatoka disease in banana
GB202112866D0 (en)2021-09-092021-10-27Tropic Biosciences Uk LtdResistance to fusarium wilt in a banana
IL286430A (en)2021-09-142023-04-01Yeda Res & DevMultispecific antibodies for use in treating diseases
CA3240113A1 (en)2021-12-082023-06-15Yeda Research And Development Co. Ltd.Multipotent lung progenitor cells for lung regeneration
WO2023209708A1 (en)2022-04-252023-11-02Yeda Research And Development Co. Ltd.Compositions for altering cyclic adp-ribose secondary messenger signalling
WO2025150045A1 (en)2024-01-122025-07-17Gabriel NussbaumBacterial targets, therapeutics, compositions, kits and methods of use in treating and/or preventing cancer

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication numberPriority datePublication dateAssigneeTitle
US3654090A (en)*1968-09-241972-04-04OrganonMethod for the determination of antigens and antibodies
US3652761A (en)*1969-09-041972-03-28Corning Glass WorksImmunochemical composites and antigen or antibody purification therewith

Also Published As

Publication numberPublication date
BR7108553D0 (en)1973-07-03
CH557030A (en)1974-12-13
GB1348938A (en)1974-03-27
DK150690B (en)1987-05-25
ZA718332B (en)1972-09-27
FI54034C (en)1978-09-11
NL7018838A (en)1972-06-30
BE777309A (en)1972-04-17
DE2164768B2 (en)1976-01-22
IL38371A0 (en)1972-02-29
JPS5834783B1 (en)1983-07-28
JPS58117455A (en)1983-07-13
AU467394B2 (en)1975-11-27
SE398557B (en)1977-12-27
FR2120835A5 (en)1972-08-18
DE2164768A1 (en)1972-07-20
FI54034B (en)1978-05-31
CA964560A (en)1975-03-18
US3839153A (en)1974-10-01
IT965020B (en)1974-01-31
NL154599B (en)1977-09-15
JPS58117456A (en)1983-07-13
DK150690C (en)1988-06-06
EG11604A (en)1977-08-15
IL38371A (en)1974-06-30
AU3698671A (en)1973-06-21
AT320145B (en)1975-01-27

Similar Documents

PublicationPublication DateTitle
ES398372A1 (en)Process for the detection and determination of specific binding proteins and their corresponding bindable substances
ES396741A1 (en)Process for the demonstration and determination of low molecular compounds and of proteins capable of binding these compounds specifically
US3654090A (en)Method for the determination of antigens and antibodies
US3720760A (en)Method for determining the presence of reagin-immunoglobulins(reagin-ig)directed against certain allergens,in aqueous samples
SE7613498L (en) PROCEDURE FOR CONNECTING BIOLOGICAL SUBSTANCES BY COVALENT BONDS
ES399608A1 (en)Process for the demonstration and determination of reaction components having specific binding affinity for each other
ES431413A1 (en)Method of detecting antigens or antibodies
ES8202364A1 (en)kit and test surface material therefor.
NL182175C (en) METHOD FOR DETECTION AND QUANTITATIVE DETERMINATION OF ANTIGENS, ANTIBODIES OR ANTIBODY-ANTIGEN IMMUNE COMPLEXES IN BIOLOGICAL LIQUIDS.
ES414618A1 (en)Improved procedure for the detection and determination of haptens. (Machine-translation by Google Translate, not legally binding)
NZ177710A (en)Determining presence of antigen or antibody in body fluid, apparatus
NL181816C (en) METHOD AND REAGENT FOR THE SPECIFIC DETERMINATION OF KREATININ.
ES8101647A1 (en)Ligand analog-irreversible enzyme inhibitor conjugates and methods for use
EP0247730A3 (en)Antibodies, their preparation and use and products containing them
NL7408726A (en) DEVICE FOR DETERMINING THE CONCENTRATION OF A FLUORESCENT COMPONENT IN A GAS SAMPLE.
DK196282A (en) METHOD AND KIT FOR DETERMINING ANTIBODIES AGAINST SOLUBLE ANTIGENS
GB1224868A (en)Sample capsule
NL162478B (en) TEST STRIP FOR DETECTION OF ACETYLAZIC ACID IN BODY LIQUIDS AND PROCEDURE FOR PREPARING A REAGENT THEREOF.
NL167519C (en) METHOD FOR DETERMINING ACCORDING TO A RADIO-IMMUNO TEST OF THE PRESENCE OF NEISSERIA-GONORRHOEAE ANTIBODIES IN HUMAN SERUM.
GB1303802A (en)
ES462699A1 (en)Process for the isolation of a placentaspecificglycoprotein
GB1540728A (en)Polyiodothyronine immunoassay
GB1151608A (en)A Method for Determining Vitamin B12
ES481490A1 (en)Method and test kit for the determination of the thyroxine binding globulin.
EP0028133A3 (en)Method of detecting and quantitating haptens and antigens
[8]ページ先頭
©2009-2025 Movatter.jp